Form990
Click to see attachment
Department of the Treasury
Internal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except black lung benefit trust or private foundation)

MediumBullet The organization may have to use a copy of this return to satisfy state reporting requirements.
OMB No. 1545-0047
2011
Open to Public Inspection
A For the calendar year, or tax year beginning 07-01-2011 and ending 06-30-2012
BCheck if applicable:
CName of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Doing Business As
 
 
Number and street (or P.O. box if mail is not delivered to street address)
1311 MAMARONECK AVENUE
ROOM/SUITE 310
Room/suite
City or town, state or country, and ZIP + 4
WHITE PLAINS, NY10605
D Employer identification number

13-5644916
E Telephone number

G Gross receipts $ 416,500,338
F Name and address of principal officer:
JOHN WALTER PRESIDENT CEO
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.LLS.ORG
H(a)
Is this a group return for
affiliates?
H(b)
Are all affiliates included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:
 
L Year of formation: 1949
M State of legal domicile: NY
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF OUR PATIENTS AND THEIR FAMILIES.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a)..... 3 26
4 Number of independent voting members of the governing body (Part VI, line 1b) .... 4 26
5 Total number of individuals employed in calendar year 2011 (Part V, line 2a) ... 5 1,942
6 Total number of volunteers (estimate if necessary) .... 6 3,000,000
7a Total unrelated business revenue from Part VIII, column (C), line 12 .. 7a 0
b Net unrelated business taxable income from Form 990-T, line 34 .. 7b  
Revenues; Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 270,364,921 282,672,073
9 Program service revenue (Part VIII, line 2g) .........   0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 10,990,644 8,039,879
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 2,476,936 2,111,041
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)................... 283,832,501 292,822,993
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 109,608,494 115,731,627
14 Benefits paid to or for members (Part IX, column (A), line 4).....   0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 83,658,857 86,776,477
16a Professional fundraising fees (Part IX, column (A), line 11e)..... 9,810,826 10,175,403
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet47,258,877    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24f).... 77,762,947 79,711,007
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 280,841,124 292,394,514
19 Revenue less expenses. Subtract line 18 from line 12....... 2,991,377 428,479
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 224,271,874 223,445,924
21 Total liabilities (Part X, line 26)............. 104,487,981 109,397,145
22 Net assets or fund balances. Subtract line 21 from line 20..... 119,783,893 114,048,779
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title.
Paid preparer use only
Print/type preparer's name
 
Preparer's signature
Date
PTIN
Firm's name Right pointing arrowhead image

Firm's EIN Right pointing arrowhead image
Firm's address Right pointing arrowhead image



Phone no.
May the IRS discuss this return with the preparer shown above? See instructions .........bullet
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y
Form 990 (2011)
Form 990 (2011)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response to any question in this Part III .........
1
Briefly describe the organization’s mission: OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF OUR PATIENTS AND THEIR FAMILIES.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? ....................
If “Yes,” describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program services? ..........................
If “Yes,” describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations and section 4947(a)(1) trusts are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 70,324,176 including grants of $ 66,713,099 ) (Revenue $   )
A) RESEARCH PROGRAMS: WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVED OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. (CONTINUED ON SCHEDULE O) TO DATE, LLS HAS INVESTED MORE THAN 875 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2012, LLS SUPPORTED RESEARCH IN THE U.S., CANADA AND 7 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY 66 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: - BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. - TURNING DISCOVERIES INTO NEW THERAPIES: FUNDAMENTAL NEW FINDINGS CAN BE TRANSLATED INTO SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. - SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. - FILLING A VOID: RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY GOVERNMENT AGENCIES OR FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. - SPEEDING NEW TREATMENTS TO PATIENTS: PARTNERING WITH BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES CAN ADVANCE PROMISING THERAPIES THROUGH CLINICAL TESTING, FASTER. PAST ADVANCES MADE WITH LLS RESEARCH FUNDING GENEROUS DONORS HAVE HELPED LLS SUPPORT RESEARCH THAT HAS ALREADY BENEFITED BLOOD CANCER PATIENTS AND MANY OTHERS. ADVANCES INCLUDE: - MULTI-DRUG THERAPIES THAT ARE MORE EFFECTIVE THAN TREATMENTS WITH SINGLE ANTI-CANCER AGENTS, - BONE MARROW / STEM CELL TRANSPLANTATION AND SUPPORTIVE CARE TREATMENTS FOR PATIENTS WHO RELAPSE DESPITE THE BEST AVAILABLE THERAPY, - TESTS THAT DISTINGUISH SPECIFIC CHARACTERISTICS OF PARTICULAR BLOOD CANCERS FOR ACCURATE DIAGNOSIS OF CANCER SUBTYPES, AND FOR "RISK STRATIFICATION" TO SELECT AN OPTIMAL THERAPY. TARGETED THERAPY RESEARCH DISCOVERING THE MOLECULAR ABNORMALITIES THAT CAUSE PARTICULAR TYPES OF BLOOD CANCER HAS BEEN USEFUL IN DIAGNOSIS AND RISK STRATIFICATION, AND IN NEW "TARGETED DRUG" DEVELOPMENT. LLS-FUNDED INVESTIGATORS HAVE HELPED ADVANCE MOLECULARLY TARGETED TREATMENTS THAT CAN SELECTIVELY KILL BLOOD CANCER CELLS VERSUS NORMAL CELLS. MANY OF THESE NEW TREATMENTS BENEFIT NOT ONLY BLOOD CANCER PATIENTS, BUT ALSO PATIENTS WITH OTHER DISEASES. FOR EXAMPLE: - GLEEVEC IS FDA-APPROVED FOR PATIENTS OF ALL AGES WITH CHRONIC MYELOID LEUKEMIA (CML), AND IS ALSO APPROVED FOR PATIENTS WITH ONE FORM OF ACUTE LYMPHOID LEUKEMIA (ALL), MYELODYSPLASTIC SYNDROMES (MDS), MYELOPROLIFERATIVE DISORDERS AND RARE FORMS OF STOMACH AND SKIN CANCERS. RELATED DRUGS, SPRYCEL AND TASIGNA, ARE APPROVED FOR PATIENTS WHO DO NOT BENEFIT FROM GLEEVEC. ONE OR MORE OF THESE DRUGS ARE ALSO SHOWING PROMISE FOR PATIENTS WITH VARIOUS LYMPHOMAS, ACUTE MYELOID LEUKEMIA (AML), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND OTHER CANCERS, INCLUDING BRAIN, BREAST, HEAD-AND-NECK, LUNG, PANCREATIC, AND PROSTATE CANCERS, AND PATIENTS WITH OTHER DISEASES INCLUDING ALZHEIMER'S, ASTHMA AND PULMONARY HYPERTENSION. - RITUXAN WAS THE FIRST FDA-APPROVED, ANTI-CANCER ANTIBODY DRUG, DEVELOPED FOR PATIENTS WITH FORMS OF B-CELL NON-HODGKIN LYMPHOMA (NHL). IT IS NOW ALSO APPROVED FOR CLL PATIENTS AND AS A "MAINTENANCE" THERAPY FOR FOLLICULAR LYMPHOMA PATIENTS, AND SHOWING PROMISE FOR PATIENTS WITH ALL AND AFTER STEM CELL TRANSPLANTATION. IN ADDITION, IT IS APPROVED FOR TREATING PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS AND TWO OTHER TYPES OF AUTOIMMUNE DISEASES. A RELATED ANTIBODY DRUG, ARZERRA, IS APPROVED FOR CLL PATIENTS AND SHOWING WIDER PROMISE. - VELCADE, THALIDOMID AND REVLIMID ARE FDA-APPROVED FOR PATIENTS WITH MYELOMA AND ARE ALSO HELPING SOME PATIENTS WITH HODGKIN LYMPHOMA AND NHL. KRYPOLIS WAS RECENTLY APPROVED FOR MYELOMA PATIENTS FOR WHOM AT LEAST TWO PRIOR THERAPIES WERE INSUFFICIENT. ONE OR MORE OF THESE DRUGS ARE NOW BEING TESTED FOR PATIENTS WITH T-CELL AND B-CELL FORMS OF LYMPHOMA, ACUTE LEUKEMIAS, AS WELL AS AIDS-RELATED KAPOSI SARCOMA AND BRAIN, BREAST, COLORECTAL, HEAD-AND-NECK, KIDNEY, LIVER, LUNG, OVARIAN AND PROSTATE CANCERS, AND ALZHEIMER'S DISEASE. - ISTODAX, ZOLINZA, DACOGEN AND VIDAZA TARGET SMALL CHEMICAL, "EPIGENETIC" CHANGES. THE FIRST TWO DRUGS ARE APPROVED FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMAS; THE LATTER DRUGS ARE APPROVED FOR MDS PATIENTS. ONE OR MORE OF THESE DRUGS ARE BEING TESTED FOR PATIENTS WITH ALL, AML, CML, CLL, MYELOMA AND FORMS OF NHL, AFTER STEM CELL TRANSPLANTATION, AND FOR PATIENTS WITH BREAST, BRAIN, KIDNEY, COLORECTAL, HEAD-AND-NECK, LUNG, STOMACH, PROSTATE AND OVARIAN CANCERS, MELANOMA AS WELL AS SICKLE CELL DISEASE AND PERSISTENT HIV INFECTIONS. OTHER ACTIVE RESEARCH DIRECTIONS LLS-FUNDED RESEARCHERS ARE ALSO EXPLORING OTHER AREAS OF RESEARCH THAT HOLD PROMISE FOR PATIENTS: - NOVEL STEM CELL TRANSPLANTATION PROCEDURES: THESE INCLUDE SO-CALLED "MINI" TRANSPLANTS THAT USE LESS TOXIC PRE-TRANSPLANT TREATMENTS AND ENGINEERED DONOR CELLS THAT HELP REDUCE POST-TRANSPLANT COMPLICATIONS, MAKING THESE POTENTIALLY CURATIVE TREATMENTS AVAILABLE TO MORE PATIENTS. - IMMUNOTHERAPIES: INCLUDING ANTIBODIES, VACCINES AND ENGINEERED IMMUNE CELLS, THESE TARGETED THERAPIES HELP A PATIENT'S IMMUNE SYSTEM FIGHT INFECTIONS AND KILL RESIDUAL CANCER CELLS, PROLONGING REMISSIONS, AND PERHAPS ONE DAY REPLACING TOXIC CHEMOTHERAPIES. - DIAGNOSTICS: NEW TECHNOLOGIES MAKE IT POSSIBLE TO CHARACTERIZE THE ABNORMALITIES IN INDIVIDUAL CANCER CASES IN MOLECULAR DETAIL. THIS INFORMATION CAN BE USED TO HELP CHOOSE THE BEST POSSIBLE TREATMENT FOR EACH PATIENT, ESPECIALLY AS MORE TARGETED THERAPIES BECOME AVAILABLE. - QUALITY OF LIFE RESEARCH: THESE STUDIES INCREASE OUR UNDERSTANDING OF HOW SPECIFIC TREATMENTS CAN CAUSE DEBILITATING SIDE-EFFECTS, INCLUDING LATE-EFFECTS, AND WHICH PATIENTS ARE AT RISK FOR DEVELOPING THESE COMPLICATIONS, SO THAT THEY CAN BE BETTER MANAGED OR EVEN PREVENTED. DRIVING RESEARCH TO ADDRESS UNMET MEDICAL NEEDS LLS CONTINUES TO SOLICIT AND SUPPORT RESEARCH FOCUSED ON IMPROVING BLOOD CANCER PATIENTS' QUALITY OF LIFE AFTER TODAY'S CURATIVE THERAPIES. ALSO IN 2012, FOR THE SECOND YEAR, LLS ACTIVELY RECRUITED RESEARCH PROPOSALS IN THREE OTHER UNDERDEVELOPED RESEARCH AREAS IN WHICH PROGRESS IS LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. NEW RESEARCH IS FOCUSED ON: - THE MALIGNANT STEM CELL IN AML AND MDS - NON-CUTANEOUS T-CELL LEUKEMIAS AND LYMPHOMAS - HIGH RISK MYELOMA CASES THE THERAPY ACCELERATION PROGRAM THIS STRATEGIC INITIATIVE WAS LAUNCHED IN 2007 TO MOVE NEW TREATMENTS AND DIAGNOSTICS THROUGH PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS, FASTER. USING MILESTONE-DRIVEN CONTRACTS AND WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, LLS IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. THE PROGRAM INCLUDES: - THE ACADEMIC CONCIERGE DIVISION IDENTIFIES ESPECIALLY PROMISING LLS-FUNDED GRANT PROJECTS AND PROVIDES ADDITIONAL SUPPORT TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. - THE BIOTECHNOLOGY ACCELERATOR DIVISION PARTNERS LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL BLOOD CANCER THERAPIES THAT OTHERWISE MIGHT NOT BE PRIORITIZED BY THE COMPANY.. - THE CLINICAL TRIALS DIVISION BRINGS CLINICAL TRIALS TO BLOOD CANCER PATIENTS IN THEIR COMMUNITIES, INCLUDING UNDER-REPRESENTED POPULATIONS, AND WITH THE ULTIMATE GOAL OF INCREASING PATIENT ENROLLMENT IN BLOOD CANCER TRIALS.
4b (Code:   ) (Expenses $ 105,745,731 including grants of $ 49,018,526 ) (Revenue $   )
B) PATIENT & COMMUNITY SERVICES: AN ESTIMATED 1,012,533 PEOPLE ACROSS THE UNITED STATES (US) CURRENTLY BATTLE LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS A FREE, COMPREHENSIVE ARRAY OF SERVICES TO BLOOD CANCER PATIENTS AND THEIR FAMILIES, VOLUNTEER CAREGIVERS AND ADVOCATES, HEALTHCARE PROFESSIONALS AND THE PUBLIC. (CONTINUED ON SCHEDULE O) LLS IS COMMITTED TO PROVIDING THE MOST ACCURATE AND UP-TO-DATE BLOOD CANCER INFORMATION. PROFESSIONAL VOLUNTEER CLINICAL ADVISORS WORK WITH LLS STAFF TO REVIEW ALL OF THE INFORMATION LLS PROVIDES THROUGH HEALTHCARE PROFESSIONAL AND PATIENT EDUCATION PROGRAMS, PUBLICATIONS AND THE LLS WEBSITE. A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. LLS PUBLISHES AN ANNUAL COMPILATION OF DATA AVAILABLE FOR BLOOD CANCERS, INCLUDING THE ESTIMATED NUMBERS OF NEW BLOOD CANCER CASES AND DEATHS, THE MOST RECENT STATISTICS AVAILABLE FOR INCIDENCE, MORTALITY AND SURVIVAL; AND CURRENT AND ACCURATE INFORMATION ABOUT SYMPTOMS, RISK FACTORS AND TREATMENT. PUBLICATIONS: AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LLS CHAPTERS. MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH AND SPANISH. - 1,077,533 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2012 FINANCIAL ASSISTANCE IN 2012, A COMBINED 48,018,526 DOLLARS WAS AWARDED TO PATIENTS THROUGH THE LLS PATIENT FINANCIAL AID (3,057,200) AND CO-PAY ASSISTANCE PROGRAMS (45,961,326). PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 46 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM PROVIDES A LIMITED AMOUNT OF FINANCIAL ASSISTANCE TO HELP PATIENTS WITH SIGNIFICANT FINANCIAL NEED AND WHO ARE UNDER A DOCTOR'S CARE FOR A CONFIRMED BLOOD CANCER DIAGNOSIS. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. - 30,603 PATIENTS RECEIVED FINANCIAL AID IN 2012 CO-PAY ASSISTANCE PROGRAM THIS CO-PAY ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 13,971 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2012 COMMUNITY PROGRAMS EACH LLS CHAPTER OFFICE IS STAFFED WITH A PATIENT SERVICES MANAGER (PSM) WHO OVERSEES SERVICES TO PATIENTS AND THEIR FAMILIES, CAREGIVERS AND HEALTHCARE PROFESSIONALS. PSMS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. PSMS SERVE AS LIAISONS WITH COMMUNITY AND REGIONAL ONCOLOGY/HEMATOLOGY HEALTHCARE PROFESSIONALS AND TREATMENT CENTERS.COMMUNITY-BASED EDUCATION AND OUTREACH, SUPPORT AND PUBLIC POLICY AND ADVOCACY PROGRAMS ARE AVAILABLE. - 43,282 PATIENT AND CAREGIVER PARTICIPANTS IN 2012 - 11,424 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2012 PROGRAMS FOR CHILDREN AND YOUNG ADULTS THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER FOCUSES ON INCREASING COMMUNICATION AMONG HEALTHCARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO SUPPORT CHILDREN, ADOLESCENTS AND YOUNG ADULTS LIVING WITH CANCER. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE IN COMMUNITIES THROUGHOUT THE US AND CANADA VIA LLS CHAPTER OFFICES. THE PROGRAM INCLUDES STAYING CONNECTED: FACILITATING THE LEARNING EXPERIENCE DURING AND AFTER CANCER TREATMENT. THIS EDUCATION PROGRAM FOR SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS DESCRIBES PHYSICAL, COGNITIVE AND PSYCHOSOCIAL SHORT-AND LONG-TERM EFFECTS THAT CHILDREN, ADOLESCENTS AND YOUNG ADULTS MAY EXPERIENCE DURING AND AFTER TREATMENT. THE PROGRAM OFFERS GUIDANCE AND NUMEROUS RESOURCES TO HELP CHILDREN, ADOLESCENTS AND YOUNG ADULTS CONTINUE THEIR EDUCATION DURING AND AFTER TREATMENT. - 2,957 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 81 STAYING CONNECTED PROGRAMS ACROSS THE US AND CANADA IN 2012. FAMILY SUPPORT GROUPS LLS HAS DEVELOPED 419 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS 786 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, PROVIDING INFORMATION AND SUPPORT AND ENCOURAGING GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTHCARE PROFESSIONALS. - 12,113 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2012 PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 6,050 FIRST CONNECTIONS IN 2012
4c (Code:   ) (Expenses $ 38,321,146 including grants of $   ) (Revenue $   )
C) PUBLIC HEALTH EDUCATION: INFORMATION AND EDUCATION INFORMATION RESOURCE CENTER PAYING FOR MEDICAL CARE, MAKING TREATMENT CHOICES, COMMUNICATING WITH HEALTHCARE PROVIDERS, FAMILY MEMBERS AND FRIENDS-THESE ARE SOME OF THE STRESSES THAT COME WITH A CANCER DIAGNOSIS. (CONTINUED ON SCHEDULE O) LLS INFORMATION SPECIALISTS ARE MASTER'S LEVEL ONCOLOGY SOCIAL WORKERS, NURSES AND HEALTH EDUCATORS WHO PROVIDE HELP WITH DISEASE, TREATMENT AND CLINICAL TRIAL INFORMATION AND SUPPORT. LLS INFORMATION SPECIALISTS CONDUCT CLINICAL-TRIAL SEARCHES TO HELP PATIENTS WORK WITH THEIR DOCTORS TO FIND OUT ABOUT SPECIFIC CLINICAL TRIALS. PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET, EMAIL INFOCENTER@LLS.ORG OR CHAT ONE-ON-ONE VIA THE LLS WEBSITE. THE INFORMATION RESOURCE CENTER OFFERS TRANSLATION SERVICES IN MORE THAN 165 LANGUAGES. - 60,012 INQUIRIES IN 2012 THE LLS WEBSITE THE LLS WEBSITE, WWW.LLS.ORG, FULFILLS A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. VISITORS CAN PERSONALIZE THEIR WEB PAGES TO KEEP CURRENT WITH DISEASE-SPECIFIC UPDATES AND COMMUNITY EDUCATION AND SUPPORT ACTIVITIES. THE WEBSITE PROVIDES ACCESS TO LLS PROGRAMS AND SERVICES, INCLUDING CO-PAY ASSISTANCE, PATIENT FINANCIAL AID, THE MOST CURRENT AND ACCURATE INFORMATION AND STATISTICS, WEEKLY FACILITATED ONLINE CHATS, NATIONAL TELEPHONE AND WEB EDUCATION PROGRAMS, PUBLICATIONS IN ENGLISH AND SPANISH, AND CLINICAL-TRIAL SEARCHES VIA AN ONLINE CLINICAL-TRIAL SEARCH SERVICE THAT OFFERS PATIENTS AND CAREGIVERS IMMEDIATE ACCESS TO LISTINGS OF BLOOD CANCER CLINICAL TRIALS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS AND ONE ANOTHER THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. NATIONAL TELEPHONE/ WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. IN 2012, 10 LLS NATIONAL EDUCATION PROGRAMS FEATURED DISEASE-SPECIFIC UPDATES AND INFORMATION ABOUT TREATMENT OPTIONS FROM WORLD RENOWNED CLINICAL EXPERTS. OPPORTUNITIES ARE PROVIDED TO ASK QUESTIONS OF EXPERTS DURING THESE PROGRAMS. MANY OF THESE PROGRAMS INCLUDE CONTINUING EDUCATION CREDITS FOR NURSES AND SOCIAL WORKERS. LLS ALSO SPONSORS A RANGE OF PROFESSIONAL EDUCATION PROGRAMS. RECENT PROGRAMS EXPLORED COMMUNICATION AMONG PRIMARY CARE PROVIDERS AND HEMATOLOGISTS/ONCOLOGISTS IN MANAGING PATIENTS WITH HEMATOLOGIC CANCER AND NURSING MANAGEMENT OF CHALLENGING SIDE EFFECTS. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. PROFESSIONAL EDUCATION PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PROFESSIONALED. LLS ALSO OFFERS DISEASE-SPECIFIC WEBCASTS PRESENTED BY WORLD RENOWNED CLINICAL EXPERTS. THESE CAN BE ACCESSED AT WWW.LLS.ORG/WEBCASTS.
(Code:   ) (Expenses $ 8,532,346 including grants of $   ) (Revenue $   )
D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT.
4d Other program services (Describe in Schedule O.)
(Expenses $ 8,532,346 including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet$ 222,923,399
Form 990 (2011)
Form 990 (2011)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If “Yes,” complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors? Click to see attachment........
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If “Yes,” complete Schedule C, Part IClick to see attachment..........
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities? If “Yes,” complete Schedule C,
Part IIClick to see attachment.........................
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If “Yes,” complete Schedule C, Part IIIClick to see attachment........................
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If “Yes,” complete Schedule D, Part IClick to see attachment....................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas or historic structures? If “Yes,” complete Schedule D, Part IIClick to see attachment...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If “Yes,” complete Schedule D, Part III Click to see attachment....................
8
Yes
 
9
Did the organization report an amount in Part X, line 21; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If “Yes,”
complete Schedule D, Part IVClick to see attachment...................
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi-endowments? If “Yes,” complete Schedule D, Part VClick to see attachment
10
Yes
 
11
If the organization’s answer to any of the following questions is ‘Yes,’ then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable:
a
Did the organization report an amount for land, buildings, and equipment in Part X, line10? If “Yes,” complete Schedule D, Part VI.Click to see attachment
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part VII.Click to see attachment
11b
Yes
 
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part VIII.Click to see attachment
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part IX.Click to see attachment
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If “Yes,” complete Schedule D, Part X.Click to see attachment
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If “Yes,” complete Schedule D, Part X.Click to see attachment
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year?
If “Yes,” complete Schedule D, Parts XI, XII, and XIII Click to see attachment
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If “Yes,” and if the organization answered ‘No’ to line 12a, then completing Schedule D, Parts XI, XII, and XIII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If “Yes,” complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States?....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States or aggregate foreign investments valued at $100,000 or more? If “Yes,” complete Schedule F, Part I......... Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or assistance to any organization or entity located outside the U.S.? If “Yes,” complete Schedule F, Part II.. Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or assistance to individuals located outside the U.S.? If “Yes,” complete Schedule F, Part III.. Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000, of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If “Yes,” complete Schedule G, Part IClick to see attachment
17
Yes
 
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If “Yes,” complete Schedule G, Part II.......... Click to see attachment
18
Yes
 
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If “Yes,” complete Schedule G, Part III................... Click to see attachment
19
Yes
 
20a
Did the organization operate one or more hospitals? If “Yes,” complete Schedule H.....
20a
 
No
b
If “Yes” to line 20a, did the organization attach a copy of its audited financial statement to this return? Note. All Form 990 filers that operated one or more hospitals must attach audited financial statements.
20b
 
 
Form 990 (2011)
Form 990 (2011)
Page 4
Part IV
Checklist of Required Schedules (continued)
21
Did the organization report more than $5,000 of grants and other assistance to any government or organization in the United States on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.. Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants and other assistance to individuals in the United States on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III..... Click to see attachment
22
Yes
 
23
Did the organization answer “Yes” to Part VII, Section A, questions 3, 4, or 5, about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If “Yes,” complete Schedule J................ Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer questions 24b–24d and complete Schedule K. If “No,” go to line 25................
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds?......................
24c
 
 
d
Did the organization act as an “on behalf of” issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3) and 501(c)(4) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If “Yes,” complete Schedule L, Part I......
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If “Yes,” complete Schedule L, Part I................
25b
 
No
26
Was a loan to or by a current or former officer, director, trustee, key employee, highly compensated employee, or disqualified person outstanding as of the end of the organization’s tax year? If “Yes,” complete Schedule L,
Part II.........................
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor or employee thereof, a grant selection committee member, or to a 35% controlled entity or family member of any of these persons? If “Yes,” complete Schedule L, Part III.........
27
 
No
28
Was the organization a party to a business transaction with one of the following parties? (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If “Yes,” complete Schedule L, Part IV .........................
28a
 
No
b
A family member of a current or former officer, director, trustee, or key employee? If “Yes,”
complete Schedule L, Part IV...................
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or owner? If “Yes,” complete Schedule L, Part IV..
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If “Yes,” complete Schedule MClick to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If “Yes,” complete Schedule M............ Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If “Yes,” complete Schedule N,
Part I...........................
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If “Yes,” complete Schedule N, Part II.......................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If “Yes,” complete Schedule R, Part I........ Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If “Yes,” complete Schedule R, Parts II, III, IV, and V, line 1..................... Click to see attachment
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
Yes
 
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If “Yes,” complete Schedule R, Part V, line 2... Click to see attachment
35b
Yes
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If “Yes,” complete Schedule R, Part V, line 2........... Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If “Yes,” complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11 and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Form 990 (2011)
Form 990 (2011)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response to any question in this Part V .........
Yes
No
1a
Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable. .......
1a
1,198
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable.
1b
22
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and Tax Statements filed for the calendar year ending with or within the year covered by this return .....................
2a
1,942
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?

Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file. (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?.............................
3a
 
No
b
If “Yes,” has it filed a Form 990-T for this year? If “No,” provide an explanation in Schedule O.....
3b
 
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account or securities account)?.......................
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletCA
See instructions for filing requirements for Form TD F 90-22.1, Report of Foreign Bank and Financial Accounts.
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year?..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If “Yes” to line 5a or 5b, did the organization file Form 8886-T? ........
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible?..........
6a
Yes
 
b
If “Yes,” did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible?........................
6b
Yes
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor?....................
7a
Yes
 
b
If “Yes,” did the organization notify the donor of the value of the goods or services provided?.....
7b
Yes
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282?...........................
7c
 
No
d
If “Yes,” indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?..........................
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract?..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required?...................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C?...............
7h
 
 
8
Sponsoring organizations maintaining donor advised funds and section 509(a)(3) supporting organizations. Did the supporting organization, or a donor advised fund maintained by a sponsoring organization, have excess business holdings at any time during the year?................
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the organization make any taxable distributions under section 4966?.........
9a
 
 
b
Did the organization make a distribution to a donor, donor advisor, or related person?......
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them) ........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If “Yes,” enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. All 501(c)(29) organizations must list in Schedule O each state in which they are licensed to issue qualified health plans, the amount of reserves required by each state, and the amount of reserves the organization allocated to each state.
13a
 
 
b
Enter the aggregate amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans.
13b
 
c
Enter the aggregate amount of reserves on hand.
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
 
b
If "Yes," has it filed a Form 720 to report these payments? If “No,” provide an explanation in Schedule O..
14b
 
 
Form 990 (2011)
Form 990 (2011)
Page 6
Part VI
Governance, Management, and Disclosure For each “Yes” response to lines 2 through 7b below, and for a “No” response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response to any question in this Part VI .........
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
If the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
1a
26
b
Enter the number of voting members included in line 1a, above, who are independent .................
1b
26
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed?
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
Yes
 
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? .................
7a
Yes
 
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ............
7b
Yes
 
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .........................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ..........
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If “Yes,” provide the names and addresses in Schedule O .....
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal
Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
Yes
 
b
If “Yes,” did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes? ....
10b
Yes
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form?
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review the Form 990. .....
12a
Did the organization have a written conflict of interest policy? If “No,” go to line 13.......
12a
Yes
 
b
Were officers, directors or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If “Yes,” describe in Schedule O how this was done ....................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes," to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If “Yes,” did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
AK , AL , AR , AZ , CA , CO , CT , DE , DC , FL , GA , HI , ID , IL , IN , KS , KY , LA , MA , MD , ME , MI , MN , MO , MS , NH , NJ , NM , NE , NY , OH , OK , OR , PA , PR , RI , SC , TN , UT , VA , WA , WI , WV
18
Section 6104 requires an organization to make its Form 1023 (or 1024 if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how), the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, physical address, and telephone number of the person who possesses the books and records of the organization: MediumBullet
JAMES T NANGLE
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
(914) 949-5213
Form 990 (2011)
Form 990 (2011)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response to any question in this Part VII .........
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation, and current key employees. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organizations compensated any current or former officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (describe hours for related organizations in Schedule O) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; Officer; Key Employee; Highest compensated employee; Former;
(1) JAMES A BECK
BOD MEMBER
 2.00 X           0 0 0
(2) WILLIAM G BEHNKE
BOD MEMBER
 2.00 X           0 0 0
(3) JORGE L BENITEZ
BOD MEMBER
 2.00 X           0 0 0
(4) PETER B BROCK
BOD MEMBER
 2.00 X           0 0 0
(5) A DANA CALLOW JR
BOD MEMBER
 2.00 X           0 0 0
(6) ELIZABETH J CLARK
BOD MEMBER
 2.00 X           0 0 0
(7) JORGE CORTES MD
BOD MEMBER
 2.00 X           0 0 0
(8) JAMES H DAVIS PHD
BOD MEMBER
 2.00 X           0 0 0
(9) BERNARD H GARIL
BOD MEMBER
 2.00 X           0 0 0
(10) D GARY GILLILAND MD PHD
BOD MEMBER
 2.00 X           0 0 0
(11) PAMELA JO HAYLOCK
BOD MEMBER
 2.00 X           0 0 0
(12) RAANAN HOROWITZ
BOD MEMBER
 2.00 X           0 0 0
(13) RICHARD M JEANNERET
BOD MEMBER
 2.00 X           0 0 0
(14) ARMAND KEATING MD
BOD MEMBER
 2.00 X           0 0 0
(15) JOSEPH B KELLEY
BOD MEMBER
 2.00 X           0 0 0
(16) MARIE V MCDEMMOND
BOD MEMBER
 2.00 X           0 0 0
(17) RODMAN N MYERS
BOD MEMBER
 2.00 X           0 0 0
Form 990 (2011)
Form 990 (2011)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (describe hours for related organizations in Schedule O) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; Officer; Key Employee; Highest compensated employee; Former;
(18) STEVEN T ROSENMDFACP
BOD MEMBER
 2.00 X           0 0 0
(19) KENNETH M SCHWARTZ
BOD MEMBER
 2.00 X           0 0 0
(20) KATHRYN C VECELLIO
BOD MEMBER
 2.00 X           0 0 0
(21) WILLIAM M WARD JR
BOD MEMBER
 2.00 X           0 0 0
(22) LOUISE E WARNER
BOD MEMBER
 2.00 X           0 0 0
(23) MATTHEW J WINTER
BOD MEMBER
 2.00 X           0 0 0
(24) JOHN WALTER
PRESIDENT &
 45.00     X       581,743 0 53,168
(25) JAMES T NANGLE
SVP&CFO
 45.00     X       244,684 0 45,548
(26) SCOTT A CARROLL
CHAIR
 2.00     X       0 0 0
(27) TIMOTHY DURST
VICE CHAIR
 2.00     X       0 0 0
(28) STEVEN HOOKER
SECRETARY/TR
 2.00     X       0 0 0
(29) LOUIS DEGENNARO
CHIEF MISSIO
 45.00         X   382,478 0 39,732
(30) NANCY KLEIN
CHIEF MARKET
 45.00         X   374,498 0 46,770
(31) RICHARD WINNEKER
SVP RESEARCH
 45.00         X   269,975 0 6,410
(32) DAVID TIMKO
SVP VOLUNTEE
 45.00         X   247,798 0 38,657
(33) MICHAEL OSSO
SVP REVENUE
 45.00         X   245,194 0 36,231
(34) JAY SILVER
BOD MEMBER
 2.00           X 0 0 0
(35) DEREK RAGHAVAN
BOD MEMBER
 2.00           X 0 0 0
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)............MediumBullet 2,346,370   266,516
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organizationMediumBullet127
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If “Yes,” complete Schedule J for such individual .............
3
Yes
 
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If “Yes,” complete Schedule J for such individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If “Yes,” complete Schedule J for such person .....
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
PARADYSZ MATERA
5 HANOVER SQUARE
NEW YORK,NY10004 		FUNDRAISING SER 2,641,112
DIRECT PRINT COMMUNICATIONS
201 EAST SANDPOINTE
SANTA ANNA,CA92707 		FUNDRASING SERV 2,324,784
INFOCISION CORPORATION
325 SPRINGSIDE DRIVE
AKRON,OH44333 		FUNDRAISING SER 2,010,620
MSP
PO BOX 641114
PITTSBURGH,PA15264 		FUNDRAISING SER 1,954,908
ROBERT MICHAEL EDUCATIONAL INSTITUT
101 LAUREL ROAD
VOORHESS,NJ08043 		EDUCATIONAL SER 1,502,644
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet72
Form 990 (2011)
Form 990 (2011)
Page 9
Part VIII
Statement of Revenue
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512, 513, or 514
Contributions, Gifts, Grants and Other Similar Amounts 1a Federated campaigns..1a 2,413,381
b Membership dues....1b  
c Fundraising events....1c 157,234,611
d Related organizations...1d  
e Government grants (contributions)1e 14,969
f All other contributions, gifts, grants, and
similar amounts not included above1f 		123,009,112
g Noncash contributions included in lines 1a-1f:$ 803,655
h Total. Add lines 1a-1f.......MediumBullet 282,672,073
Program Service Revenue Business Code
2a
b
c
d
e
f All other program service revenue .        
g Total. Add lines 2a–2f........MediumBullet  
Other Revenue 3 Investment income (including dividends, interest
and other similar amounts).....MediumBullet 2,703,601     2,703,601
4 Income from investment of tax-exempt bond proceeds..MediumBullet        
5 Royalties............MediumBullet 1,445     1,445
(i) Real (ii) Personal
6a Gross rents    
b Less: rental expenses    
c Rental income or (loss)    
d Net rental income or (loss).......MediumBullet        
(i) Securities (ii) Other
7a Gross amount from sales of assets other than inventory 91,812,719  
b Less: cost or other basis and sales expenses 86,476,441  
c Gain or (loss) 5,336,278  
d Net gain or (loss)..........MediumBullet 5,336,278     5,336,278
8a Gross income from fundraising events (not including
$ 157,234,611
of contributions reported on line 1c). See Part IV, line 18 ...
a 36,867,938
b Less: direct expenses ...b 36,867,938
c Net income or (loss) from fundraising events..MediumBullet      
9a Gross income from gaming activities.
See Part IV, line 19 ...
a 940,518
b Less: direct expenses ...b 332,966
c Net income or (loss) from gaming activities...MediumBullet 607,552 607,552    
10a Gross sales of inventory, less
returns and allowances .
a  
b Less: cost of goods sold ..b  
c Net income or (loss) from sales of inventory..MediumBullet        
Miscellaneous Revenue Business Code
11a GRANT TERMINATION 541,900 1,477,090     1,477,090
b OTHER MISCELLANEOUS 900,099 24,954     24,954
c            
d All other revenue ....        
e Total. Add lines 11a–11d ......MediumBullet 1,502,044
12 Total revenue. See Instructions....MediumBullet 292,822,993 607,552   9,543,368
Form 990 (2011)
Form 990 (2011)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A) but are not required to complete columns (B), (C), and (D).
Check if Schedule O contains a response to any question in this Part IX. .........
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to governments and organizations in the United States. See Part IV, line 21 60,600,563 60,600,563
2 Grants and other assistance to individuals in the United States. See Part IV, line 22 49,018,526 49,018,526
3 Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16 6,112,538 6,112,538
4 Benefits paid to or for members    
5 Compensation of current officers, directors, trustees, and key employees .... 934,832 693,373 108,381 133,078
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....        
7 Other salaries and wages 65,894,279 48,874,387 7,639,571 9,380,321
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 3,977,818 2,789,860 475,995 711,963
9 Other employee benefits ....... 11,297,662 7,923,662 1,351,904 2,022,096
10 Payroll taxes ........... 4,671,886 3,276,647 559,048 836,191
11 Fees for services (non-employees):        
a Management ......        
b Legal ......... 657,011 373,063 102,391 181,557
c Accounting ........... 256,761 145,793 40,014 70,954
d Lobbying ........... 568,404 322,748 88,583 157,073
e Professional fundraising. See Part IV, line 17.. 10,175,403 10,175,403
f Investment management fees ...... 598,320 339,738 93,244 165,338
g Other .......... 14,166,395 8,043,931 2,207,736 3,914,728
12 Advertising and promotion .... 5,841,570 2,397,725 1,155,048 2,288,797
13 Office expenses .......        
14 Information technology ...... 4,127,452 2,343,640 643,234 1,140,578
15 Royalties ..        
16 Occupancy ........... 8,500,974 6,090,214 1,018,748 1,392,012
17 Travel ............ 3,864,333 2,773,731 479,994 610,608
18 Payments of travel or entertainment expenses for any federal, state, or local public officials ......        
19 Conferences, conventions, and meetings .... 4,068,549 3,420,109 289,541 358,899
20 Interest ...........        
21 Payments to affiliates .......        
22 Depreciation, depletion, and amortization ..... 2,719,990 1,757,140 343,440 619,410
23 Insurance .............. 523,304 365,915 55,456 101,933
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24f. If line 24f amount exceeds 10% of line 25, column (A) amount, list line 24f expenses on Schedule O.)
a PRINTING 16,202,162 6,650,325 3,203,634 6,348,203
b POSTAGE 10,330,621 3,787,901 1,588,979 4,953,741
c MISCELLANEOUS 3,514,511 2,500,416 410,393 603,702
d TELEPHONE 3,475,172 2,200,173 298,479 976,520
e
f All other expenses 295,478 121,281 58,425 115,772
25 Total functional expenses. Add lines 1 through 24f 292,394,514 222,923,399 22,212,238 47,258,877
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720). 19,790,406 9,427,344   10,363,062
Form 990 (2011)
Form 990 (2011)
Page 11
Part X Balance Sheet
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash—non-interest-bearing ..........   1  
2 Savings and temporary cash investments ....... 15,624,105 2 23,567,530
3 Pledges and grants receivable, net ......... 19,055,089 3 5,178,782
4 Accounts receivable, net ......... 328,134 4 264,507
5 Receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of
Schedule L ..........   5  
6 Receivables from other disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B). Complete Part II of
Schedule L ..........   6  
7 Notes and loans receivable, net .............   7  
8 Inventories for sale or use ..............   8  
9 Prepaid expenses and deferred charges ............ 4,423,864 9 5,875,009
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 17,733,329
b Less: accumulated depreciation. ..... 10b 11,092,269 5,182,309 10c 6,641,060
11 Investments—publicly traded securities .......... 128,104,890 11 138,026,930
12 Investments—other securities. See Part IV, line 11 ...... 51,553,483 12 43,892,106
13 Investments—program-related. See Part IV, line 11 ..   13  
14 Intangible assets .........   14  
15 Other assets. See Part IV, line 11 ...........   15  
16 Total assets. Add lines 1 through 15 (must equal line 34)... 224,271,874 16 223,445,924
Liabilities 17 Accounts payable and accrued expenses . 17,155,530 17 19,660,610
18 Grants payable .......... 70,833,146 18 72,815,341
19 Deferred revenue .......... 16,499,305 19 16,921,194
20 Tax-exempt bond liabilities ..........   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D..   21  
22 Payables to current and former officers, directors, trustees, key
employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L..........   22  
23 Secured mortgages and notes payable to unrelated third parties ..   23  
24 Unsecured notes and loans payable to unrelated third parties ....   24  
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D.....   25  
26 Total liabilities. Add lines 17 through 25..... 104,487,981 26 109,397,145
Net Assets or Fund Balance Organizations that follow SFAS 117, check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets ..... 93,670,008 27 100,978,174
28 Temporarily restricted net assets ..... 23,328,394 28 10,221,074
29 Permanently restricted net assets ..... 2,785,491 29 2,849,531
Organizations that do not follow SFAS 117, check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds .....   30  
31 Paid-in or capital surplus, or land, building or equipment fund .....   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ..... 119,783,893 33 114,048,779
34 Total liabilities and net assets/fund balances ..... 224,271,874 34 223,445,924
Form 990 (2011)
Form 990 (2011)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response to any question in this Part XI .........
1
Total revenue (must equal Part VIII, column (A), line 12) ...
1
292,822,993
2
Total expenses (must equal Part IX, column (A), line 25) ....
2
292,394,514
3
Revenue less expenses. Subtract line 2 from line 1 ...
3
428,479
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) ..
4
119,783,893
5
Other changes in net assets or fund balances (explain in Schedule O) ...
5
-6,163,593
6
Net assets or fund balances at end of year. Combine lines 3, 4, and 5 (must equal Part X, line 33, column (B)) ....
6
114,048,779
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response to any question in this Part XII .........
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?....
2a
 
No
b
Were the organization’s financial statements audited by an independent accountant?........
2b
Yes
 
c
If “Yes,” to 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant? If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O. ...........................
2c
Yes
 
d
If “Yes” to line 2a or 2b, check a box below to indicate whether the financial statements for the year were issued on a separate basis, consolidated basis, or both:
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133? ................
3a
 
No
b
If “Yes,” did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits. ..
3b
 
 
Form 990 (2011)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section
4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ. right arrow See separate instructions.
OMB No. 1545-0047
2011
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions
The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)
1
2
3
4
5
section 170(b)(1)(A)(iv). (Complete Part II.)
6
7
8
9
receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of
its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses
acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)
10
11
e
f
g
(i) a person who directly or indirectly controls, either alone or together with persons described in (ii)
Yes
No
and (iii) below, the governing body of the the supported organization? ................
11g(i)
 
 
(ii) a family member of a person described in (i) above? ......................
11g(ii)
 
 
(iii) a 35% controlled entity of a person described in (i) or (ii) above? ................
11g(iii)
 
 
h
(i)
Name of supported organization 		(ii)
EIN 		(iii)
Type of organization (described on lines 1- 9 above or IRC section (see instructions)) 		(iv)
Is the organization in col. (i) listed in your governing document? 		(v)
Did you notify the organization in col. (i) of your support? 		(vi)
Is the organization in col. (i) organized in the U.S.? 		(vii)
Amount of support?
Yes No Yes No Yes No
Total                  

For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2011
Schedule A (Form 990 or 990-EZ) 2011
Page 2
Part II
Support Schedule for Organizations Described in IRC 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year(or fiscal year beginning in) (a) 2007 (b) 2008 (c) 2009 (d) 2010 (e) 2011 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... 256,914,242 269,156,149 238,668,944 270,731,343 283,279,625 1,318,750,303
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3.. 256,914,242 269,156,149 238,668,944 270,731,343 283,279,625 1,318,750,303
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..           83,283,998
6 Public Support. Subtract line 5 from line 4.           1,235,466,305
Section B. Total Support
Calendar year(or fiscal year beginning in) (a) 2007 (b) 2008 (c) 2009 (d) 2010 (e) 2011 (f) Total
7 Amounts from line 4.. 256,914,242 269,156,149 238,668,944 270,731,343 283,279,625 1,318,750,303
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. 7,451,748 6,950,554 4,962,639 3,145,637 2,705,046 25,215,624
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. 1,098,580 2,816,918 1,925,834 1,779,485 1,502,044 9,122,861
11 Total support (Add lines 7 through 10).           1,353,088,788
12
12
187,378,474
13
Section C. Computation of Public Support Percentage
14
14
91.310 %
15
15
94.640 %
16a
b
17a
b
18
Schedule A (Form 990 or 990-EZ) 2011
Schedule A (Form 990 or 990-EZ) 2011
Page 3
Part III
Support Schedule for Organizations Described in IRC 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year(or fiscal year beginning in) (a) 2007 (b) 2008 (c) 2009 (d) 2010 (e) 2011 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......            
3 Gross receipts from activities that are not an unrelated trade or business under section 513..            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge..            
6 Total. Add lines 1 through 5.            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons...            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public Support (Subtract line 7c from line 6.)            
Section B. Total Support
Calendar year (or fiscal year beginning in) (a) 2007 (b) 2008 (c) 2009 (d) 2010 (e) 2011 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)            
13 Total support (Add lines 9, 10c, 11 and 12.).            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2011
Schedule A (Form 990 or 990-EZ) 2011
Page 4
Part IV
Supplemental Information. Supplemental Information. Complete this part to provide the explanation required by Part II, line 10; Part II, line 17a or 17b; or Part III, line 12. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Explanation
 
 
 
 
Schedule A (Form 990 or 990-EZ) 2011

Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors
Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
OMB No. 1545-0047
2011
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ





Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......................... Arrow Bullet   $    
Caution. An Organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on Part I, line 2, of its Form 990-PF, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2011)

Page 2
Schedule B (Form 990, 990-EZ, or 990-PF) (2011)
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
  		Employer identification number

13-5644916
Part I
Contributors (see Instructions). Use duplicate copies of Part I if additional space is needed.
     
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
RESTRICTED
 

     
RESTRICTED
RESTRICTED  
RESTRICTED, RESTRICTED   RESTRICTED

$RESTRICTED




(Complete Part II if there is a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is a noncash contribution.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2011)

Page 3
Schedule B (Form 990, 990-EZ, or 990-PF) (2011)
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
  		Employer identification number

13-5644916
Part II
Noncash Property (see Instructions). Use duplicate copies of Part II if additional space is needed.
     
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions). 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions). 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions). 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions). 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions). 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions). 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2011)

Page 4
Schedule B (Form 990, 990-EZ, or 990-PF) (2011)
Name of organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
  		Employer identification number

13-5644916
Part III
Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet $  
Use duplicate copies of Part III if additional space is needed
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2011)

Additional Data


Software ID:  
Software Version:  
SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet Complete if the organization is described below.
SchCMd Bullet Attach to Form 990 or Form 990-EZ. SchCMd Bullet See separate instructions.
OMB No. 1545-0047
2011
Open to Public
Inspection
If the organization answered “Yes” to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered “Yes” to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)) Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered “Yes” to Form 990, Part IV, Line 5 (Proxy Tax) or Form 990-EZ, line 35c (Proxy Tax), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization’s direct and indirect political campaign activities in Part IV.
2
Political expenditures ....................................SchCMd Bullet
$  
3
Volunteer hours ........................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 .........SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 ......SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............
4a
Was a correction made? .........................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c) except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ...................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b..SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ..........................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.










For Privacy Act and Paperwork Reduction Act Notice, see the instructions for Form 990.
Cat. No. 50084S
Schedule C (Form 990 or 990-EZ) 2011

Schedule C (Form 990 or 990-EZ) 2011
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check expenses, and share of excess lobbying expenditures).
B Check
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
organization's
totals 		(b) Affiliated group
totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ......    
b Total lobbying expenditures to influence a legislative body (direct lobbying) .......    
c Total lobbying expenditures (add lines 1a and 1b) ...................    
d Other exempt purpose expenditures ........................    
e Total exempt purpose expenditures (add lines 1c and 1d) ...............    
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		    
  If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:    
  Not over $500,00020% of the amount on line 1e.    
  Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.    
  Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.    
  Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.    
  Over $17,000,000$1,000,000.    
       
g Grassroots nontaxable amount (enter 25% of line 1f) .................    
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................    
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................    
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ......................................

4-Year Averaging Period Under Section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the instructions for lines 2a through 2f on page 4.)
Lobbying Expenditures During 4-Year Averaging Period
  Calendar year (or fiscal year
beginning in) 		(a) 2008 (b) 2009 (c) 2010 (d) 2011 (e) Total
             
2a Lobbying non-taxable amount          
             
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		         
             
c Total lobbying expenditures          
             
d Grassroots nontaxable amount          
             
e Grassroots ceiling amount
(150% of line 2d, column (e))		          
             
f Grassroots lobbying expenditures          
Schedule C (Form 990 or 990-EZ) 2011


Schedule C (Form 990 or 990-EZ) 2011
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
For each “Yes” response to lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.
(a)
Yes
No
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? .........................................
Yes
 
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....
Yes
 
c
Media advertisements? ....................................
 
No
 
d
Mailings to members, legislators, or the public? .........................
 
No
 
e
Publications, or published or broadcast statements? .......................
Yes
 
121,269
f
Grants to other organizations for lobbying purposes? .......................
 
No
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? ........
Yes
 
264,232
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......
 
No
 
i
Other activities? ..........................
Yes
 
568,404
j
Total. Add lines 1c through 1i ...............................
953,905
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
No
b
If "Yes," enter the amount of any tax incurred under section 4912 .................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......
 
No
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ................
1
 
No
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ................
2
 
No
3
Did the organization agree to carry over lobbying and political expenditures from the prior year? ..........
3
 
No
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2 are answered “No” OR (b) Part III-A, line 3 is answered “Yes”.
1
Dues, assessments and similar amounts from members .....................
1
 
2
Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).
a
Current year .........................................
2a
 
b
Carryover from last year ....................................
2b
 
c
Total ...........................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................
4
 
5
Taxable amount of lobbying and political expenditures (see instructions) ..............
5
 
Part IV
Supplemental Information
Complete this part to provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, Part II-A; line 5; and Part ll-B, line 1.
Also, complete this part for any additional information.
Identifier Return Reference Explanation
  SCHEDULE C, PART II-B, LINE 1 LLS IS A MEMBER OF A NUMBER OF COALITIONS INCLUDING RESEARCH AMERICA, ONE VOICE AGAINST CANCER, NATIONAL COALITION FOR CANCER RESEARCH, COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH, ALLIANCE FOR A STRONGER FDA, FRIENDS OF CANCER RESEARCH, PATIENT ADVOCATE FOUNDATION, AND THE CENTER FOR ADVANCED HEALTH. LLS PARTNERS WITH A NUMBER OF LOBBYING FIRMS WHO WORK WITH OUR PUBLIC POLICY STAFF TO CARRY OUT OUR LOBBYING OBJECTIVES.
Schedule C (Form 990 or 990EZ) 2011

Additional Data


Software ID:  
Software Version:  

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet Attach to Form 990. SchDMd Bullet See separate instructions.
OMB No. 1545-0047
2011
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .......    
2 Aggregate contributions to (during year) ...    
3 Aggregate grants from (during year) ...    
4 Aggregate value at end of year .......    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ....................... 2a  
b Total acreage restricted by conservation easements .................. 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register .................... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................
6
Staff and volunteer hours devoted to monitoring, inspecting and enforcing conservation easements during the year SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section
170(h)(4)(B)(i) and 170(h)(4)(B)(ii)? ....................................
9
In Part XIV, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of
art, historical treasures, or other similar assets held for public exhibition, education or research in furtherance of public service,
provide, in Part XIV, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art,
historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service,
provide the following amounts relating to these items:
(i)
Revenues included in Form 990, Part VIII, line 1 ........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ..............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958), relating to these items:
a
Revenues included in Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Privacy Act and Paperwork Reduction Act Notice, see the Intructions for Form 990
Cat. No. 52283D
Schedule D (Form 990) 2011

Schedule D (Form 990) 2011
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s accession and other records, check any of the following that are a significant use of its collection
items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIV.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b
If "Yes," explain the arrangement in Part XIV and complete the following table:
Amount
c Beginning balance ................................. 1c  
d Additions during the year .............................. 1d  
e Distributions during the year ............................. 1e  
f Ending balance ................................... 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21? .....................
b
If “Yes,” explain the arrangement in Part XIV.
Part V
Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.
(a)Current Year (b)Prior Year (c)Two Years Back (d)Three Years Back (e)Four Years Back
1a Beginning of year balance .... 6,059,994 5,023,902 4,481,610 5,228,375
b Contributions ........   111,064    
c Net investment earnings, gains, and losses ... 48,916 938,068 563,236 730,333
d Grants or scholarships .....        
e Other expenditures for facilities
and programs ........ 		       
f Administrative expenses .... -9,992 -13,040 -20,944 -16,432
g End of year balance ...... 6,000,186 6,059,994 5,023,902 4,481,610
2
Provide the estimated percentage of the year end balance (line 1g) held as:
a
Board designated or quasi-endowment SchDMd Bullet  
b
Permanent endowment SchDMd Bullet53.000 %
c
Temporarily restricted endowment SchDMd Bullet47.000 %
The percentages in lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations ........................
3a(i)
 
No
(ii) related organizations ........................
3a(ii)
 
No
b
If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
No
4
Describe in Part XIV the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis (investment) (b)Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .................      
b Buildings ................        
c Leasehold improvements ............   903,003 730,475 172,528
d Equipment ................   15,354,736 9,351,645 6,003,091
e Other .................   1,475,590 1,010,149 465,441
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......SchDMdBullet 6,641,060
Schedule D (Form 990) 2011

Schedule D (Form 990) 2011
Page 3
Part VII
Investments—Other Securities. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b)Book value (c) Method of valuation:
Cost or end-of-year market value
(1)Financial derivatives    
(2)Closely-held equity interests    
(3)Other
(A) FUND OF HEDGE FUNDS- OPERATING 		36,168,519 F

(B) LIMITED PARTNERSHIP EQUITIES-OPERATI 		4,979,287 F

(C) FUND OF HEDGE FUNDS-ENDOWMENT 		1,274,336 F

(D) 457B PLAN 		1,195,568 F

(E) LIMITED PARTNERSHIP EQUITIES-ENDOWME 		274,396 F




Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet 43,892,106
Part VIII
Investments—Program Related. See Form 990, Part X, line 13.
(a) Description of investment type (b) Book value (c) Method of valuation:
Cost or end-of-year market value








Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. See Form 990, Part X, line 15.
(a) Description (b) Book value








Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities. See Form 990, Part X, line 25.
1.(a) Description of Liability (b) Book value
Federal Income Taxes  








Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet  
2. Fin 48 (ASC 740) Footnote. In Part XIV, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC740).
Schedule D (Form 990) 2011

Schedule D (Form 990) 2011
Page 4
Part XI Reconciliation of Change in Net Assets from Form 990 to Financial Statements
1 Total revenue (Form 990, Part VIII, column (A), line 12) .................... 1 292,822,993
2 Total expenses (Form 990, Part IX, column (A), line 25) ..................... 2 292,394,514
3 Excess or (deficit) for the year. Subtract line 2 from line 1 ............. 3 428,479
4 Net unrealized gains (losses) on investments .......................... 4 -5,492,300
5 Donated services and use of facilities ............................. 5  
6 Investment expenses ................................... 6  
7 Prior period adjustments .................................. 7  
8 Other (Describe in Part XIV.) ................................. 8 -1,202,263
9 Total adjustments (net). Add lines 4 through 8 ......................... 9 -6,694,563
10 Excess or (deficit) for the year per financial statements. Combine lines 3 and 9 ......... 10 -6,266,084
Part XII Reconciliation of Revenue per Audited Financial Statements With Revenue per Return
1 Total revenue, gains, and other support per audited financial statements ....... 1 305,088,769
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains on investments .......... 2a -5,492,300
b Donated services and use of facilities ......... 2b 5,328,250
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIV.) ............ 2d 13,028,146
e Add lines 2a through 2d ..................... 2e 12,864,096
3 Subtract line 2e from line 1..................... 3 292,224,673
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a 598,320
b Other (Describe in Part XIV.) ........... 4b  
c Add lines 4a and 4b....................... 4c 598,320
5 Total Revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5 292,822,993
Part XIII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return
1 Total expenses and losses per audited financial statements ............. 1 311,221,456
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities .......... 2a 5,328,250
b Prior year adjustments .............. 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIV.) ............ 2d 14,097,012
e Add lines 2a through 2d...................... 2e 19,425,262
3 Subtract line 2e from line 1..................... 3 291,796,194
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a 598,320
b Other (Describe in Part XIV.) ............ 4b  
c Add lines 4a and 4b....................... 4c 598,320
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5 292,394,514
Part XIV
Supplemental Information
Complete this part to provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X; Part XI, line 8; Part XII, lines 2d and 4b; and Part XIII, lines 2d and 4b. Also complete this part to provide any additional information.
Identifier Return Reference Explanation
COLLECTIONS AND RELATION TO EXEMPT PURPOSE SCHEDULE D, PAGE 2, PART III, LINE 4 THE LLS COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS.
INTENDED USES FOR ENDOWMENT FUNDS SCHEDULE D, PAGE 2, PART V, LINE 4 LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS.
LIABILITY UNDER FIN 48 FOOTNOTE SCHEDULE D, PAGE 3, PART X LLS RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE TAX POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO LLS'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. LLS DID NOT RECOGNIZE ANY UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2012 AND 2011.
RECONCILIATION OF CHANGES - OTHER SCHEDULE D, PAGE 4, PART XI, LINE 8 LLS CANADA REVENUE 12,985,138 LSRP REVENUE 43,009 ROUNDING -1 LLS CANADA EXPENSES -13,424,218 LSRP -1,502 UNCOLLECTABLE MULTI-YEAR PLEDGES -671,292
REVENUE AMOUNTS INCLUDED IN FINANCIALS - OTHER SCHEDULE D, PAGE 4, PART XII, LINE 2D LLS CANADA REVENUE 12,985,138 LSRP REVENUE 43,009 ROUNDING -1
EXPENSE AMOUNTS INCLUDED IN FINANCIALS - OTHER SCHEDULE D, PAGE 4, PART XIII, LINE 2D LLS CANADA EXPENSES 13,424,218 LSRP 1,502 UNCOLLECTABLE MULTI-YEAR PLEDGES 671,292
SUPPLEMENTAL FINANCIAL INFORMATION SCHEDULE D, PAGE 4, PART XIV LLS MAINTAINS A SMALL PHOTOGRAPH COLLECTION FOR PUBLIC EXHIBITION WHICH HAS AN ESTIMATED VALUE BETWEEN 20,000 AND 50,000. AS THIS REPRESENTS A RELATIVELY SMALL PERCENTAGE OF LLS'S ASSETS, IT IS NOT SEPERATELY DISCLOSED IN THE FINANCIAL STATEMENTS OR FOOTNOTES.
Schedule D (Form 990) 2011

Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990. Right pointing arrow large image See separate instructions.
OMB No. 1545-0047
2011
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
General Information on Activities Outside the United States. Complete if the organization answered
“Yes” to Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants
and other assistance, the grantees' eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? ..............................
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other
assistance outside the United States.
3
Activites per Region. (Use Part V if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees or agents in region or independent contractors (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total
expenditures for region/investments
in region
EAST ASIA 2 2 RESEARCH FUNDING RESEARCH GRANTS 1,450,000
EUROPE 6 8 RESEARCH FUNDING RESEARCH GRANTS 1,821,142
NORTH AMERICA 12 19 RESEARCH FUNDING RESEARCH GRANTS 2,641,396
MIDDLE EAST 1 1 RESEARCH FUNDING RESEARCH GRANTS 200,000
CENTRAL AMERICA & CARIBBEAN     INVESTMENTS INVESTMENTS  
           
           
           
           
           
           
           
           
           
           
           
           
3a Sub-total ..... 21 30 25,281,986
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b) 21 30 25,281,986
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2011
Schedule F (Form 990) 2011
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990,
Part IV, line 15, for any recipient who received more than $5,000. Check this box if no one recipient received more than $5,000 ........ MediumBullet
Use Part V if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount of
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
EAST ASIA & PACIFIC RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 110,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
MIDDLE EAST RESEARCH GRANT 200,000 CHECK     ACCRUAL
EAST ASIA & PACIFIC RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 110,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA THERAPY ACCELERATION 75,000 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 49,925 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 31,475 CHECK     FMV
EUROPE THERAPY ACCELERATION 21,142 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 9,996 CHECK     FMV
EAST ASIA & PACIFIC RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 110,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
MIDDLE EAST RESEARCH GRANT 200,000 CHECK     ACCRUAL
EAST ASIA & PACIFIC RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 110,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA THERAPY ACCELERATION 75,000 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 49,925 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 31,475 CHECK     FMV
EUROPE THERAPY ACCELERATION 21,142 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 9,996 CHECK     FMV
2
Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .....MediumBullet
 
3
Enter total number of other organizations or entities ........................MediumBullet
21
Schedule F (Form 990) 2011
Schedule F (Form 990) 2011Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Use Part V if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2011
Schedule F (Form 990) 2011
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926 (see instructions for Form 926).................
2 Did the organization have an interest in a foreign trust during the tax year? If " Yes," the organization may be required to file Form 3520 and/or Form 3520-A. (see instructions for Forms 3520 and 3520-A)..........
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with respect to Certain Foreign Corporations. (see instructions for Form 5471)..............................
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If "Yes," the organization may be required to file Form 8621, Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see instructions for Form 8621)
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with respect to Certain Foreign Partnerships. (see instructions for Form 8865)....................................
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see instructions for Form 5713)................................................
Schedule F (Form 990) 2011
Schedule F (Form 990) 2011
Page 5
Part V
Supplemental Information
Complete this part to provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).
Identifier ReturnReference Explanation
PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE THE UNITED STATES SCHEDULE F, PAGE 1, PART I, LINE 2 FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT.
    EAST ASIA 1,450,000 0 EUROPE 1,821,142 0 NORTH AMERICA 2,641,396 0 MIDDLE EAST 200,000 0 CENTRAL AMERICA & CARIBBEAN 0 19,169,448
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
Schedule F (Form 990) 2011
Additional Data


Software ID:  
Software Version:  



SCHEDULE G (Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Supplemental Information Regarding
Fundraising or Gaming Activities
Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19,or if the organization entered more than $15,000 on Form 990-EZ, line 6a.right arrowAttach to Form 990 or Form 990-EZ. right arrowSee separate instructions.
OMB No. 1545-0047
2011
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.
1
Indicate whether the organization raised funds through any of the following activities. Check all that apply.
a e
b f
c g
d
2a
Did the organization have a written or oral agreement with any individual (including officers, directors, trustees
or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?
b
If “Yes,” list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization. Form 990-EZ filers are not required to complete this table.
(i) Name and address of individual
or entity (fundraiser) 		(ii) Activity (iii) Did fundraiser have custody or control of contributions? (iv) Gross receipts
from activity 		(v) Amount paid to
(or retained by)
fundraiser listed in
col. (i) 		(vi) Amount paid to
(or retained by)
organization
Yes No
 
PARADYZ MATERA
5 HANOVER SQUARE 6TH FLOOR
 
NEW YORK, NY10004 		DIRECT MAI   No   2,641,112 -2,641,112
 
DIRECT PRINT COMMUNICATIONS
201 EAST SANDPOINTE SUITE 400
 
SANTA ANA, CA92707 		DIRECT MAI   No   2,324,784 -2,324,784
 
INFOCISION
325 SPRINSIDE DRIVE
 
AKRON, OH44333 		TELEMARKET   No   2,010,620 -2,010,620
 
MSP
PO BOX 641114
 
PITTSBURGH, PA15264 		DIRECT MAI   No   1,954,908 -1,954,908
 
THOMPSON HABIB & DENISON
80 HAYDEN AVENUE SUITE 300
 
LEXINGTON, MA02421 		DIRECT MAI   No   664,097 -664,097
 
HAINES & COMPANY
8050 FREEDOM AVENUE
 
CANTON, OH44720 		TELEMARKET   No   261,594 -261,594
 
BLACKBAUD
1800 DIAGONAL ROAD SUITE 400
 
ALEXANDRIA, VA22314 		DIRECT MAI   No   191,860 -191,860
 
DONOR CARE CENTER INC
4345 STRAUSSSER ST NW
 
NOTH CANTON, OH44720 		TELEMARKET   No   126,428 -126,428
Total .................right arrow   10,175,403  
3
List all states in which the organization is registered or licensed to solicit funds or has been notified it is exempt from registration or licensing.
All States
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50083H
Schedule G (Form 990 or 990-EZ) 2011
Schedule G (Form 990 or 990-EZ) 2011
Page 2
Part II
Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 on Form 990-EZ, line 6a. List events with gross receipts greater than $5,000.
(a) Event #1

NIKE WOMENS MAR
(event type) 		(b) Event #2

ROCK N ROLL MAR
(event type) 		(c) Other Events

1,051
(total number) 		(d) Total Events
(Add col. (a) through col. (c))
VerticalRevenue 1 Gross receipts . . . 10,133,172 6,943,611 177,025,766 194,102,549
2 Less: Charitable
contributions . . . 		7,218,103 4,823,819 145,192,689 157,234,611
3 Gross income (line 1
minus line 2) . . . 		2,915,069 2,119,792 31,833,077 36,867,938
VerticalDirectExpenses 4 Cash prizes . . .        
5 Non-cash prizes . .        
6 Rent/facility costs . .        
7 Food and beverages . .        
8 Entertainment . . .        
9 Other direct expenses . 2,915,069 2,119,792 31,833,077 36,867,938
10 Direct expense summary. Add lines 4 through 9 in column (d) ........... right arrow 36,867,938
11 Net income summary. Combine lines 3 and 10 in column (d)............ right arrow  
Part III
Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.
VerticalRevenue (a) Bingo (b) Pull tabs/Instant
bingo/progressive bingo 		(c) Other gaming (d) Total gaming (Add col. (a) through col. (c))
1 Gross revenue . . . .     940,518 940,518
VerticalDirectExpenses 2 Cash prizes . . . .     5,208 5,208
3 Non-cash prizes . . .     290,575 290,575
4 Rent/facility costs . . .     20,511 20,511
5 Other direct expenses . .     16,672 16,672
6 Volunteer labor . . .
 
 
12.000 %
7 Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow 332,966
8 Net gaming income summary. Combine lines 1 and 7 in column (d) .......... right arrow 607,552
9
Enter the state(s) in which the organization operates gaming activities:
a
Is the organization licensed to operate gaming activities in each of these states? ............
b
If "No," Explain:
 
10a
Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....
b
If "Yes," Explain:
 
11
Does the organization operate gaming activities with nonmembers? .................
12
Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity
formed to administer charitable gaming? ..........................
Schedule G (Form 990 or 990-EZ) 2011
Schedule G (Form 990 or 990-EZ) 2011
Page 3
13
Indicate the percentage of gaming activity operated in:
a
The organization's facility ......................
13a
1.000 %
b
An outside facility ........................
13b
99.000 %
14
Provide the name and address of the person who prepares the organization's gaming/special events books and records:
Name right arrow
JAMES T NANGLE
Address right arrow
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
15a
Does the organization have a contract with a third party from whom the organization receives gaming
revenue? ......................................
b
If "Yes," enter the amount of gaming revenue received by the organization right arrow $   and the
amount of gaming revenue retained by the third party right arrow $   .
c
If "Yes," enter name and address:
Name right arrow
Address right arrow
 
 
16
Gaming manager information:
Name right arrow
Gaming manager compensation right arrow $  
Description of services provided right arrow
 
17
Mandatory distributions:
a
Is the organization required under state law to make charitable distributions from the gaming proceeds to
retain the state gaming license? ............................
b
Enter the amount of distributions required under state law distributed to other exempt organizations or spent
in the organization's own exempt activities during the tax year right arrow$  
Part IV
Complete this part to provide additional information for responses to quuestion on Schedule G (see instructions.)
Identifier ReturnReference Explanation
    SCHEDULE G PART I LINE 2B LLS USED INFOCISON HAINES COMPANY DONOR CARE CENTER INC AND THOMPSON HABIB DENISON FOR ITS NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS THESE PROGRAMS GENERATED GROSS RECEIPTS OF 26431738 DURING FISCAL YEAR 2012LLS USED DIRECT PRINT COMMUNICATIONS PARADYZ MATERA AND BLACKBAUD FOR ALL OF ITS OTHER FUNDRAISING EVENTS DURING FISCAL YEAR 2012 SCHEDULE G PART III LINE 9STATES WITH GAMING OPERATIONS ARIZONA CALIFORNIA CONNECTICUT DISTRICT OF COLUMBIA FLORIDA GEORGIA ILLINOIS IOWA KANSAS LOUISIANA MASSACHUSETTS MARYLAND MICHIGAN MINNESOTA MISSISSIPPI NEVADA NEW JERSEY NEW YORK OHIO OREGON PENNSYLVANIA RHODE ISLAND TEXAS VIRGINIA WASHINGTON WISCONSIN
Schedule G (Form 990 or 990-EZ) 2011
Additional Data


Software ID:  
Software Version:  
Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990
OMB No. 1545-0047
2011
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number
13-5644916
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21 for any recipient that received more than $5,000. Check this box if no one recipient received more than $5,000. Use
Part IV and Schedule I-1 (Form 990) if additional space is needed ......................... lBullet
(a) Name and address of organization
or government		 (b) EIN (c) IRC Code section
if applicable		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
non-cash assistance		 (h) Purpose of grant
or assistance
(1) ALBERT EINSTEIN COLLEGE OF MEDICINE1300 MORRIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(2) ALBERT EINSTEIN COLLEGE OF MEDICINE1300 MORRIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(3) ALBERT EINSTEIN COLLEGE OF MEDICINE1300 MORRIS PARK AVE
BRONX,NY10461 		13-1624225 3 110,000   ACCRUAL   RESEARCH GRANT
(4) BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 65,000   ACCRUAL   RESEARCH GRANT
(5) BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 1,250,000   ACCRUAL   RESEARCH GRANT
(6) BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(7) BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(8) BECKMAN RESEARCH INSTITUTE OF THE C1500 EAST DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(9) BECKMAN RESEARCH INSTITUTE OF THE C1500 EAST DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(10) BECKMAN RESEARCH INSTITUTE OF THE C1500 EAST DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(11) BETH ISRAEL DEACONESS MEDICAL CENTE330 BROOKLINE AVENUE
BOSTON,MA02108 		04-2103881 3 200,000   ACCRUAL   RESEARCH GRANT
(12) BETH ISRAEL DEACONESS MEDICAL CENTE330 BROOKLINE AVENUE
BOSTON,MA02108 		04-2103881 3 55,000   ACCRUAL   RESEARCH GRANT
(13) BETH ISRAEL DEACONESS MEDICAL CENTE330 BROOKLINE AVENUE
BOSTON,MA02108 		04-2103881 3 65,000   ACCRUAL   RESEARCH GRANT
(14) BRANDEIS UNIVERSITY415 SOUTH STREET
WALTHAM,MA02453 		04-2103552 3 55,000   ACCRUAL   RESEARCH GRANT
(15) BRIGHAM AND WOMEN'S HOSPITAL INC1 BLACKFAN CIRCLE
BOSTON,MA02115 		04-2312909 3 110,000   ACCRUAL   RESEARCH GRANT
(16) BRIGHAM AND WOMEN'S HOSPITAL INC1 JIMMY FUND WAYSMITH BUILDING ROO
BOSTON,MA02115 		04-2312909 3 110,000   ACCRUAL   RESEARCH GRANT
(17) BRIGHAM AND WOMEN'S HOSPITAL INC75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 65,000   ACCRUAL   RESEARCH GRANT
(18) BRIGHAM AND WOMEN'S HOSPITAL INC75 FRANCIS STREET
BOSTON,MA02115 		04-2312909 3 1,250,000   ACCRUAL   RESEARCH GRANT
(19) CHILDRENS HOSPITAL LOS ANGELES4650 SUNSET BLVD
LOS ANGELES,CA90001 		95-1690977 3 200,000   ACCRUAL   RESEARCH GRANT
(20) CHILDRENS HOSPITAL LOS ANGELES513 PARNASSUS AVENUE
SAN FRANCISCO,CA94143 		95-1690977 3 110,000   ACCRUAL   RESEARCH GRANT
(21) CHILDRENS HOSPITAL LOS ANGELES513 PARNASSUS AVENUE
SAN FRANCISCO,CA94143 		95-1690977 3 200,000   ACCRUAL   RESEARCH GRANT
(22) CHILDRENS HOSPITAL MEDICAL CENTER-C7013 3333 BURNET AVENUE
CINCINNATI,OH45202 		31-0833936 3 200,000   ACCRUAL   RESEARCH GRANT
(23) CHILDRENS HOSPITAL MEDICAL CENTER-C7013 3333 BURNET AVENUE
CINCINNATI,OH45202 		31-0833936 3 110,000   ACCRUAL   RESEARCH GRANT
(24) CHILDRENS HOSPITAL MEDICAL CENTER-C7013 3333 BURNET AVENUE
CINCINNATI,OH45202 		31-0833936 3 110,000   ACCRUAL   RESEARCH GRANT
(25) CHILDRENS HOSPITAL MEDICAL CENTER-C7013 3333 BURNET AVENUE
CINCINNATI,OH45202 		31-0833936 3 200,000   ACCRUAL   RESEARCH GRANT
(26) CHILDRENS HOSPITAL OF BOSTON300 LONGWOOD AVENUE
BOSTON,MA02108 		04-2774441 3 110,000   ACCRUAL   RESEARCH GRANT
(27) CLEVELAND CLINIC FOUNDATION9500 EUCLID AVENUE
CLEVELAND,OH44195 		34-0714553 3 200,000   ACCRUAL   RESEARCH GRANT
(28) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 1,250,000   ACCRUAL   RESEARCH GRANT
(29) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(30) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(31) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(32) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(33) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 110,000   ACCRUAL   RESEARCH GRANT
(34) COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(35) CORNELL UNIVERSITY1300 YORK AVENUEROOM C-338
NEW YORK,NY10065 		15-0532082 3 200,000   ACCRUAL   RESEARCH GRANT
(36) DANA FARBER CANCER INSTITUTE450 BROOKLINE AVEN
BOSTON,MA02115 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(37) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(38) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(39) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(40) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(41) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(42) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(43) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(44) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 100,000   ACCRUAL   RESEARCH GRANT
(45) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(46) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(47) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(48) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(49) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(50) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(51) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(52) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(53) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(54) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(55) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(56) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(57) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(58) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(59) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(60) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(61) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(62) DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(63) DREXEL UNIVERSITY497 245 N 15TH STREET
PHILADELPHIA,PA19102 		23-1352630 3 110,000   ACCRUAL   RESEARCH GRANT
(64) DUKE UNIVERSITY MEDICAL CENTER3813 BOX RESEARCH DRIVE
DURHAM,NC27710 		56-0532129 3 55,000   ACCRUAL   RESEARCH GRANT
(65) DUKE UNIVERSITY MEDICAL CENTER3813 BOX RESEARCH DRIVE
DURHAM,NC27710 		56-0532129 3 110,000   ACCRUAL   RESEARCH GRANT
(66) EMORY UNIVERSITY1599 CLIFTON ROAD NE
ATLANTA,GA30303 		58-0566256 3 110,000   ACCRUAL   RESEARCH GRANT
(67) FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 200,000   ACCRUAL   RESEARCH GRANT
(68) FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 200,000   ACCRUAL   RESEARCH GRANT
(69) FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 55,000   ACCRUAL   RESEARCH GRANT
(70) FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 65,000   ACCRUAL   RESEARCH GRANT
(71) HARVARD MEDICAL SCHOOL1 BLACKFAN CIRCLE
BOSTON,MA02108 		53-0199180 3 65,000   ACCRUAL   RESEARCH GRANT
(72) HARVARD MEDICAL SCHOOL1 BLACKFAN CIRCLE
BOSTON,MA02108 		53-0199180 3 55,000   ACCRUAL   RESEARCH GRANT
(73) HARVARD MEDICAL SCHOOL1 BLACKFAN CIRCLE
BOSTON,MA02108 		53-0199180 3 65,000   ACCRUAL   RESEARCH GRANT
(74) HEALTH RESEARCH INCORPORATED ROSWE1 ELM CARLTON STREETS
BUFFALO,NY14201 		14-1402155   110,000   ACCRUAL   RESEARCH GRANT
(75) INDIANA UNIVERSITY1044 W WALNUT STREET
INDIANAPOLIS,IN46201 		35-6018940 3 200,000   ACCRUAL   RESEARCH GRANT
(76) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 55,000   ACCRUAL   RESEARCH GRANT
(77) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 65,000   ACCRUAL   RESEARCH GRANT
(78) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(79) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(80) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(81) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(82) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(83) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(84) JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(85) JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(86) JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(87) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 55,000   ACCRUAL   RESEARCH GRANT
(88) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(89) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(90) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(91) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(92) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(93) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(94) JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 65,000   ACCRUAL   RESEARCH GRANT
(95) LA JOLLA INSTITUTE FOR ALLERGY & IM9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 65,000   ACCRUAL   RESEARCH GRANT
(96) LA JOLLA INSTITUTE FOR ALLERGY & IM9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 200,000   ACCRUAL   RESEARCH GRANT
(97) LA JOLLA INSTITUTE FOR ALLERGY AND9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 55,000   ACCRUAL   RESEARCH GRANT
(98) LA JOLLA INSTITUTE FOR ALLERGY AND9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 65,000   ACCRUAL   RESEARCH GRANT
(99) LUDWIG INSTITUTE FOR CANCER RESEARC9500 GILMAN DRIVECMM-EAST
LA JOLLA,CA92093 		23-7121131 3 65,000   ACCRUAL   RESEARCH GRANT
(100) MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 55,000   ACCRUAL   RESEARCH GRANT
(101) MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 110,000   ACCRUAL   RESEARCH GRANT
(102) MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 65,000   ACCRUAL   RESEARCH GRANT
(103) MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 55,000   ACCRUAL   RESEARCH GRANT
(104) MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 55,000   ACCRUAL   RESEARCH GRANT
(105) MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 110,000   ACCRUAL   RESEARCH GRANT
(106) MASSACHUSETTS INSTITUTE OF TECHNOLO77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02138 		04-2103594 3 55,000   ACCRUAL   RESEARCH GRANT
(107) MASSACHUSETTS INSTITUTE OF TECHNOLO77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02138 		04-2103594 3 55,000   ACCRUAL   RESEARCH GRANT
(108) MAYO CLINIC ARIZONA DBA MAYO CLI13400 EAST SHEA BOULEVARD
SCOTTSDALE,AZ85250 		86-0800150 3 200,000   ACCRUAL   RESEARCH GRANT
(109) MAYO CLINIC ARIZONA DBA MAYO CLI13400 EAST SHEA BOULEVARD
SCOTTSDALE,AZ85250 		86-0800150 3 200,000   ACCRUAL   RESEARCH GRANT
(110) MAYO CLINIC ARIZONA DBA MAYO CLI13400 EAST SHEA BOULEVARD
SCOTTSDALE,AZ85250 		86-0800150 3 200,000   ACCRUAL   RESEARCH GRANT
(111) MAYO CLINIC JACKSONVILLE4500 SAN PABLO RD
JACKSONVILLE,FL32224 		59-3337028 3 100,000   ACCRUAL   RESEARCH GRANT
(112) MAYO CLINIC ROCHESTER200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 110,000   ACCRUAL   RESEARCH GRANT
(113) MAYO CLINIC ROCHESTER200 FIRST STREET SW
ROCHESTER,MN55905 		41-1506440 3 100,000   ACCRUAL   RESEARCH GRANT
(114) MAYO CLINIC ROCHESTER200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 200,000   ACCRUAL   RESEARCH GRANT
(115) MAYO CLINIC ROCHESTER200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 200,000   ACCRUAL   RESEARCH GRANT
(116) MAYO CLINIC ROCHESTER200 FIRST STREET SW
ROCHESTER,MN55905 		41-6011702 3 110,000   ACCRUAL   RESEARCH GRANT
(117) MEDICAL COLLEGE OF WISCONSIN8701 WATERTOWN PLANK ROAD
MILWAUKEE,WI53226 		39-0806261 3 110,000   ACCRUAL   RESEARCH GRANT
(118) MEMORIAL SLOAN KETTERING CANCER CEN633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 55,000   ACCRUAL   RESEARCH GRANT
(119) MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 55,000   ACCRUAL   RESEARCH GRANT
(120) MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 110,000   ACCRUAL   RESEARCH GRANT
(121) MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 200,000   ACCRUAL   RESEARCH GRANT
(122) MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 65,000   ACCRUAL   RESEARCH GRANT
(123) MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 65,000   ACCRUAL   RESEARCH GRANT
(124) MOUNT SINAI SCHOOL OF MEDICINE1079 ONE GUSTAVE L LEVY PLACE
NEW YORK,NY10029 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(125) MOUNT SINAI SCHOOL OF MEDICINE1130 ONE GUSTAVE L LEVY PLACE
NEW YORK,NY10029 		13-6171197 3 110,000   ACCRUAL   RESEARCH GRANT
(126) MPN RESEARCH FOUNDATION180 N MICHIGAN AVENUE
CHICAGO,IL60601 		36-4330967 3 200,000   ACCRUAL   RESEARCH GRANT
(127) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(128) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 65,000   ACCRUAL   RESEARCH GRANT
(129) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 65,000   ACCRUAL   RESEARCH GRANT
(130) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(131) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(132) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 65,000   ACCRUAL   RESEARCH GRANT
(133) NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 110,000   ACCRUAL   RESEARCH GRANT
(134) NORTHWESTERN UNIVERSITY - CHICAGO C303 EAST SUPERIOR STREET
CHICAGO,IL60601 		36-2656113 3 200,000   ACCRUAL   RESEARCH GRANT
(135) NORTHWESTERN UNIVERSITY - CHICAGO C303 EAST SUPERIOR STREET
CHICAGO,IL60601 		36-2656113 3 55,000   ACCRUAL   RESEARCH GRANT
(136) NORTHWESTERN UNIVERSITY - CHICAGO C303 E SUPERIOR STREET
CHICAGO,IL60611 		36-2656113 3 1,250,000   ACCRUAL   RESEARCH GRANT
(137) OREGON HEALTH & SCIENCE UNIVERSITY3181 SW SAM JACKSON PARK RD
PORTLAND,OR97239 		23-7083114 3 1,250,000   ACCRUAL   RESEARCH GRANT
(138) OREGON HEALTH & SCIENCE UNIVERSITY3181 SW SAM JACKSON PARK RD
PORTLAND,OR97239 		23-7083114 3 110,000   ACCRUAL   RESEARCH GRANT
(139) SAINT LOUIS UNIVERSITY1402 SOUTH GRAND AVE
SAINT LOUIS,MO63104 		43-0654872 3 200,000   ACCRUAL   RESEARCH GRANT
(140) SLOAN-KETTERING INSTITUTE FOR CANCE1275 YORK AVENUE
NEW YORK,NY10065 		13-1924236 3 1,250,000   ACCRUAL   RESEARCH GRANT
(141) SLOAN-KETTERING INSTITUTE FOR CANCE1275 YORK AVENUE
NEW YORK,NY10021 		13-1924236 3 200,000   ACCRUAL   RESEARCH GRANT
(142) SLOAN-KETTERING INSTITUTE FOR CANCE1275 YORK AVENUE
NEW YORK,NY10065 		13-1924236 3 55,000   ACCRUAL   RESEARCH GRANT
(143) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 65,000   ACCRUAL   RESEARCH GRANT
(144) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 110,000   ACCRUAL   RESEARCH GRANT
(145) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 65,000   ACCRUAL   RESEARCH GRANT
(146) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 55,000   ACCRUAL   RESEARCH GRANT
(147) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 200,000   ACCRUAL   RESEARCH GRANT
(148) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 200,000   ACCRUAL   RESEARCH GRANT
(149) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 200,000   ACCRUAL   RESEARCH GRANT
(150) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 1,250,000   ACCRUAL   RESEARCH GRANT
(151) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 110,000   ACCRUAL   RESEARCH GRANT
(152) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 200,000   ACCRUAL   RESEARCH GRANT
(153) STANFORD UNIVERSITY9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 55,000   ACCRUAL   RESEARCH GRANT
(154) STANFORD UNIVERSITY MEDICAL CENTER3901 LICKMILL BLVD
SANTA CLARA,CA95054 		77-0465765 3 65,000   ACCRUAL   RESEARCH GRANT
(155) STANFORD UNIVERSITY MEDICAL CENTER279 CAMPUS DRIVE
STANFORD,CA94305 		77-0465765 3 55,000   ACCRUAL   RESEARCH GRANT
(156) STANFORD UNIVERSITY MEDICAL CENTER279 CAMPUS DRIVE
STANFORD,CA94305 		77-0465765 3 65,000   ACCRUAL   RESEARCH GRANT
(157) THE BOARD OF TRUSTEES OF THE LELAND279 CAMPUS DRIVE WEST
STANFORD,CA94305 		37-6000511 3 55,000   ACCRUAL   RESEARCH GRANT
(158) THE BOARD OF TRUSTEES OF THE UNIVER900 S ASHLAND AVE
CHICAGO,IL60607 		37-6000511 3 110,000   ACCRUAL   RESEARCH GRANT
(159) THE CBR INSTITUTE FOR BIOMEDICAL RE1 BLACKFAN CIRCLE
BOSTON,MA02115 		04-2158520   1,250,000   ACCRUAL   RESEARCH GRANT
(160) THE CHILDREN'S HOSPITAL OF PHILADEL3615 CIVIC CENTER BLVD
PHILADELPHIA,PA19104 		23-1352166 3 110,000   ACCRUAL   RESEARCH GRANT
(161) THE OHIO STATE UNIVERSITY320 WEST 10TH AVENUE
COLUMBUS,OH43210 		31-6401599 3 65,000   ACCRUAL   RESEARCH GRANT
(162) THE OHIO STATE UNIVERSITY320 WEST 10TH AVENUE
COLUMBUS,OH43210 		31-6401599 3 55,000   ACCRUAL   RESEARCH GRANT
(163) THE OHIO STATE UNIVERSITY320 WEST 10TH AVENUE
COLUMBUS,OH43210 		31-6401599 3 200,000   ACCRUAL   RESEARCH GRANT
(164) THE OHIO STATE UNIVERSITY320 WEST 10TH AVENUE
COLUMBUS,OH43210 		31-6401599 3 1,250,000   ACCRUAL   RESEARCH GRANT
(165) THE REGENTS OF THE UNIVERSITY OF CA731 STANLEY HALL MS 3220
BERKELEY,CA94720 		94-6002123 3 55,000   ACCRUAL   RESEARCH GRANT
(166) THE REGENTS OF THE UNIVERSITY OF CA731 STANLEY HALL MS 3220
BERKELEY,CA94720 		94-6002123 3 55,000   ACCRUAL   RESEARCH GRANT
(167) THE REGENTS OF THE UNIVERSITY OF CA731 STANLEY HALL MS 3220
BERKELEY,CA94720 		94-6002123 3 65,000   ACCRUAL   RESEARCH GRANT
(168) THE REGENTS OF THE UNIVERSITY OF CA2150 SHATTUCK AVENUE SUITE 313
BERKELEY,CA94704 		94-6002123 3 55,000   ACCRUAL   RESEARCH GRANT
(169) THE REGENTS OF THE UNIVERSITY OF CA11000 KINROSS AVENUE SUITE 102
LOS ANGELES,CA90095 		95-6006143 3 65,000   ACCRUAL   RESEARCH GRANT
(170) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LOS ANGELES,CA90095 		95-6006143 3 110,000   ACCRUAL   RESEARCH GRANT
(171) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LOS ANGELES,CA90095 		95-6006143 3 55,000   ACCRUAL   RESEARCH GRANT
(172) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LA JOLLA,CA92093 		95-2872494 3 110,000   ACCRUAL   RESEARCH GRANT
(173) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LA JOLLA,CA92093 		95-2872494 3 55,000   ACCRUAL   RESEARCH GRANT
(174) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LA JOLLA,CA92093 		95-2872494 3 55,000   ACCRUAL   RESEARCH GRANT
(175) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LA JOLLA,CA92093 		95-2872494 3 110,000   ACCRUAL   RESEARCH GRANT
(176) THE REGENTS OF THE UNIVERSITY OF CA9500 GILMAN DRIVE
LA JOLLA,CA92093 		95-2872494 3 110,000   ACCRUAL   RESEARCH GRANT
(177) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 65,000   ACCRUAL   RESEARCH GRANT
(178) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(179) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(180) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(181) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(182) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(183) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(184) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(185) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 65,000   ACCRUAL   RESEARCH GRANT
(186) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(187) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(188) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(189) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(190) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(191) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(192) THE REGENTS OF THE UNIVERSITY OF CA505 PARNASSUS AVENUESUITE M1286 BO
SAN FRANCISCO,CA94143 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(193) UNIVERSITY OF CALIFORNIA AT SAN FRA3333 CALIFORNIA STREET SUITE 315
SAN FRANCISCO,CA94143 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(194) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(195) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(196) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(197) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(198) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(199) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(200) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(201) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(202) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(203) THE ROCKEFELLER UNIVERSITY1230 YORK AVENUE BOX 202
NEW YORK,NY10065 		13-1624158 3 55,000   ACCRUAL   RESEARCH GRANT
(204) THE ROCKEFELLER UNIVERSITY1230 YORK AVENUE BOX 202
NEW YORK,NY10065 		13-1624158 3 55,000   ACCRUAL   RESEARCH GRANT
(205) THE ROCKEFELLER UNIVERSITY1230 YORK AVENUE BOX 202
NEW YORK,NY10065 		13-1624158 3 65,000   ACCRUAL   RESEARCH GRANT
(206) THE ROCKEFELLER UNIVERSITY1230 YORK AVENUE BOX 202
NEW YORK,NY10065 		13-1624158 3 110,000   ACCRUAL   RESEARCH GRANT
(207) THE SCRIPPS RESEARCH INSTITUTE10550 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 3 110,000   ACCRUAL   RESEARCH GRANT
(208) THE SCRIPPS RESEARCH INSTITUTE10550 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 3 110,000   ACCRUAL   RESEARCH GRANT
(209) THE UNIVERSITY OF ALABAMA AT BIRMIN720 SOUTH 20TH STREET
BIRMINGHAM,AL35294 		63-6001138 3 110,000   ACCRUAL   RESEARCH GRANT
(210) THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
CHICAGO,IL60601 		36-2177139 3 110,000   ACCRUAL   RESEARCH GRANT
(211) THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
CHICAGO,IL60601 		36-2177139 3 65,000   ACCRUAL   RESEARCH GRANT
(212) THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
CHICAGO,IL60601 		36-2177139 3 55,000   ACCRUAL   RESEARCH GRANT
(213) THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
CHICAGO,IL60601 		36-2177139 3 200,000   ACCRUAL   RESEARCH GRANT
(214) THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
CHICAGO,IL60601 		36-2177139 3 55,000   ACCRUAL   RESEARCH GRANT
(215) TRUSTEES OF DARTMOUTH COLLEGE1 MEDICAL CENTER DRIVE
LEBANON,NH03756 		02-0222111 3 200,000   ACCRUAL   RESEARCH GRANT
(216) UMDNJ--ROBERT WOOD JOHNSON MEDICAL335 GEORGE STREET
NEW BRUNSWICK,NJ08901 		22-1776306 3 200,000   ACCRUAL   RESEARCH GRANT
(217) UNIV OF TEXAS HEALTH SCIENCE CENTER8230 14960 OMICRON DRIVE
SAN ANTONIO,TX78245 		74-1717115 3 200,000   ACCRUAL   RESEARCH GRANT
(218) UNIV OF TEXAS HEALTH SCIENCE CENTER8230 14960 OMICRON DRIVE
SAN ANTONIO,TX78245 		74-1717115 3 200,000   ACCRUAL   RESEARCH GRANT
(219) UNIVERSITY OF ARKANSAS FOR MEDICAL4301 WEST MARKHAM 7
LITTLE ROCK,AR72205 		71-6046242 3 200,000   ACCRUAL   RESEARCH GRANT
(220) UNIVERSITY OF CINCINNATI231 ALBERT SABIN WAY
CINCINNATI,OH45202 		31-6000989 3 110,000   ACCRUAL   RESEARCH GRANT
(221) UNIVERSITY OF COLORADO3415 COLORADO AVE UCB 596
AURORA,CO80045 		84-6000555 3 65,000   ACCRUAL   RESEARCH GRANT
(222) UNIVERSITY OF COLORADO3415 COLORADO AVE UCB 596
AURORA,CO80045 		84-6000555 3 55,000   ACCRUAL   RESEARCH GRANT
(223) UNIVERSITY OF COLORADO DENVER3415 COLORADO AVE UCB 596
AURORA,CO80045 		84-6000555 3 200,000   ACCRUAL   RESEARCH GRANT
(224) UNIVERSITY OF COLORADO DENVER3415 COLORADO AVE UCB 596
AURORA,CO80045 		84-6000555 3 200,000   ACCRUAL   RESEARCH GRANT
(225) UNIVERSITY OF COLORADO AT BOULDER3415 COLORADO AVE UCB 596
AURORA,CO80045 		84-6000555 3 55,000   ACCRUAL   RESEARCH GRANT
(226) UNIVERSITY OF FLORIDA113001 PO BOX
GAINESVILLE,FL32601 		59-6002052 3 110,000   ACCRUAL   RESEARCH GRANT
(227) UNIVERSITY OF FLORIDA113001 PO BOX
GAINESVILLE,FL32601 		59-6002052 3 200,000   ACCRUAL   RESEARCH GRANT
(228) UNIVERSITY OF MARYLAND BALTIMORE655 WEST BALTIMORE STREET
BALTIMORE,MD21201 		52-6002033 3 200,000   ACCRUAL   RESEARCH GRANT
(229) UNIVERSITY OF MARYLAND BALTIMORE655 WEST BALTIMORE STREET
BALTIMORE,MD21201 		52-6002033 3 200,000   ACCRUAL   RESEARCH GRANT
(230) UNIVERSITY OF MASSACHUSETTS MEDICAL364 PLANTATION STREET
WORCESTER,MA01605 		04-3167352 3 55,000   ACCRUAL   RESEARCH GRANT
(231) UNIVERSITY OF MASSACHUSETTS MEDICAL364 PLANTATION STREET
WORCESTER,MA01605 		04-3167352 3 110,000   ACCRUAL   RESEARCH GRANT
(232) UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(233) UNIVERSITY OF MINNESOTA - TWIN CITI321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 110,000   ACCRUAL   RESEARCH GRANT
(234) UNIVERSITY OF MINNESOTA - TWIN CITI321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 200,000   ACCRUAL   RESEARCH GRANT
(235) UNIVERSITY OF MINNESOTA - TWIN CITI321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 110,000   ACCRUAL   RESEARCH GRANT
(236) UNIVERSITY OF NORTH CAROLINA AT CHA450 WEST DRIVE
CHAPEL HILL,NC27599 		56-6001393 3 55,000   ACCRUAL   RESEARCH GRANT
(237) UNIVERSITY OF NORTH CAROLINA HOSPIT450 WEST DRIVE ROOM 22-039
CHAPEL HILL,NC27599 		56-6001393 3 200,000   ACCRUAL   RESEARCH GRANT
(238) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(239) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(240) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 55,000   ACCRUAL   RESEARCH GRANT
(241) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 55,000   ACCRUAL   RESEARCH GRANT
(242) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(243) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(244) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(245) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(246) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 1,250,000   ACCRUAL   RESEARCH GRANT
(247) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(248) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(249) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(250) UNIVERSITY OF PENNSYLVANIA421 CURIE BOULEVARD BRBII/IIIRM 53
PHILADELPHIA,PA19104 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(251) UNIVERSITY OF PITTSBURGH5117 CENTER AVE
PITTSBURGH,PA15213 		25-0965591 3 110,000   ACCRUAL   RESEARCH GRANT
(252) UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 200,000   ACCRUAL   RESEARCH GRANT
(253) UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 110,000   ACCRUAL   RESEARCH GRANT
(254) UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 200,000   ACCRUAL   RESEARCH GRANT
(255) UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 200,000   ACCRUAL   RESEARCH GRANT
(256) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(257) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(258) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(259) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(260) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(261) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(262) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(263) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(264) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(265) UNIVERSITY OF TEXAS MD ANDERSON C1515 HOLCOMBE BLVD
HOUSTON,TX77030 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(266) UNIVERSITY OF TEXAS SOUTHWESTERN ME5323 HARRY HINES BOULEVARD
DALLAS,TX75390 		75-6002868 3 55,000   ACCRUAL   RESEARCH GRANT
(267) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 110,000   ACCRUAL   RESEARCH GRANT
(268) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(269) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 55,000   ACCRUAL   RESEARCH GRANT
(270) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(271) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(272) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(273) UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(274) UNIVERSITY OF VERMONT149 BEAUMONT AVE
BURLINGTON,VT05405 		03-0179440 3 65,000   ACCRUAL   RESEARCH GRANT
(275) UNIVERSITY OF WASHINGTON1100 NE 45TH STREET
SEATTLE,WA98105 		91-6001537 3 110,000   ACCRUAL   RESEARCH GRANT
(276) UT SOUTHWESTERN MEDICAL CENTER5323 HARRY HINES BLVD
DALLAS,TX75390 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(277) UT SOUTHWESTERN MEDICAL CENTER5323 HARRY HINES BLVD
DALLAS,TX75390 		76-0300816 3 55,000   ACCRUAL   RESEARCH GRANT
(278) VIRGINIA COMMONWEALTH UNIVERSITY401 COLLEGE STREET
RICHMOND,VA23298 		54-6001758 3 200,000   ACCRUAL   RESEARCH GRANT
(279) WASHINGTON UNIVERSITY IN ST LOUIS660 SOUTH EUCLID AVE
SAINT LOUIS,MO63110 		43-0653611 3 200,000   ACCRUAL   RESEARCH GRANT
(280) WASHINGTON UNIVERSITY SCHOOL OF MED660 SOUTH EUCLID AVE
SAINT LOUIS,MO63110 		91-6001537 3 110,000   ACCRUAL   RESEARCH GRANT
(281) WHITEHEAD INSTITUTE FOR BIOMEDICAL9 CAMBRIDGE CENTER
CAMBRIDGE,MA02138 		06-1043412 3 110,000   ACCRUAL   RESEARCH GRANT
(282) WHITEHEAD INSTITUTE FOR BIOMEDICAL9 CAMBRIDGE CENTER
CAMBRIDGE,MA02138 		06-1043412 3 65,000   ACCRUAL   RESEARCH GRANT
(283) YALE UNIVERSITY208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(284) YALE UNIVERSITY208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(285) YALE UNIVERSITY208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(286) YALE UNIVERSITY208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(287) SHAPE55 CAMBRIDGE PARKWAY
CAMBRIDGE,MA02142 		26-3714475   3,600,000   FMV   THERAPY ACCELERATION
(288) MEMORIAL SLAON KETTERING633 THIRD AVENUE
NEW YORK,NY10017 		91-2154267 3 1,956,100   FMV   THERAPY ACCELERATION
(289) CELATOR PHARMACEUTICALS303B COLLEGE ROAD EAST
PRINCETON,NJ08540 		20-2680869   1,888,218   FMV   THERAPY ACCELERATION
(290) EPIZYME INC325 VASSAR STREET
CAMBRIDGE,MA02139 		26-1349956   1,500,000   FMV   THERAPY ACCELERATION
(291) ACETYLON PHARMACEUTICALS70 FARGO STREET
BOSTON,MA02210 		26-3506788   1,340,000   FMV   THERAPY ACCELERATION
(292) AVILA100 BEAVER STREET
WALTHAM,MA02453 		20-4599701   517,483   FMV   THERAPY ACCELERATION
(293) BECKLOFF ASSOCIATES INC3203 SOLUTIONS CENTER
CHICAGO,IL60677 		48-0842223   525,686   FMV   THERAPY ACCELERATION
(294) CHARLES RIVER LABS251 BALLARDVALLE STREET
WILMINGTON,MA01887 		43-0918770   509,300   FMV   THERAPY ACCELERATION
(295) JOHN HOPKINS UNIVERSITY4545 NORTH CHARLES STREET
BALTIMORE,MD21210 		52-0595110 3 500,000   FMV   THERAPY ACCELERATION
(296) NANOSYN INC3760 MAVEN AVE
MENLO PARK,CA94025 		86-0909295   207,346   FMV   THERAPY ACCELERATION
(297) FORMA THERAPEUTICS790 MEMORIAL DRIVE
CAMBRIDGE,MA02139 		26-0428600   200,000   FMV   THERAPY ACCELERATION
(298) CELGENE AVILOMIC RESEARCH45 WIGGINS AVENUE
BEDFORD,MA01731 		20-4599701   150,000   FMV   THERAPY ACCELERATION
(299) CLEVELAND CLINIC931568 PO BOX
CLEVELAND,OH44193 		34-0714585   118,000   FMV   THERAPY ACCELERATION
(300) CHILDRENS HOSPITAL OF BOSTON414413 PO BOX
BOSTON,MA02241 		04-2774441 3 100,000   FMV   THERAPY ACCELERATION
(301) UNIVERSITY OF KANSAS2385 IRVING HILL ROAD
LAWRENCE,KS66045 		48-0680117 3 100,000   FMV   THERAPY ACCELERATION
(302) THE REGENTS OF THE UNIVERSITY OF MI1500 E MEDICAL CENTER DRIVE
PITTSBURGH,PA15251 		38-6006309 3 60,372   FMV   THERAPY ACCELERATION
(303) KUMC OUTPATIENT PHARMACY3901 RAINBOW BLVD
KANSAS CITY,KS66160 		48-1202402   58,160   FMV   THERAPY ACCELERATION
(304) ABC LABORATORIES INC4780 DISCOVERY DRIVE
COLUMBIA,MO65201 		43-0918770   54,623   FMV   THERAPY ACCELERATION
(305) SMITHERS PHARMA SERVICES75711 PO BOX
CLEVELAND,OH44101 		20-1922115   25,500   FMV   THERAPY ACCELERATION
(306) PEPTISYNTHA INC23424 NETWORK PLACE
CHICAGO,IL60673 		76-0315292   10,000   FMV   THERAPY ACCELERATION
(307) AMERICAN PEPTIDE1271 AVENIDA CHELSEA
VISTA,CA92081 		94-3057367   9,275   FMV   THERAPY ACCELERATION
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
289
3
Enter total number of other organizations listed in the line 1 table ......................... . Bullet Image
19
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2011

Schedule I (Form 990) 2011
Page 2
Part III
Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Use Schedule I-1 (Form 990) if additional space is needed.
(a)Type of grant or assistance (b)Number of
recipients		 (c)Amount of
cash grant		 (d)Amount of
non-cash assistance		 (e)Method of valuation (book,
FMV, appraisal, other)		 (f)Description of non-cash assistance
(1) PATIENT AID 30572 3,057,200      
(2) COPAY ASSISTANCE CML 461 416,269      
(3) COPAY ASSISTANCE CLL 1618 4,759,699      
(4) COPAY ASSISTANCE LYMPHOMA 6326 20,625,358      
(5) COPAY ASSISTANCE MDS 1213 2,160,000      
(6) COPAY ASSISTANCE MYELOMA 4353 18,000,000      



Part IV
Supplemental Information. Complete this part to provide the information required in Part I, line 2, and any other additional information.
Identifier Return Reference Explanation
PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE UNITED STATES SCHEDULE I, PAGE 1, PART I, LINE 2 FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT.
Schedule I (Form 990) 2011


Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" to Form 990,
Part IV, question 23.
SchJMediumBullet Attach to Form 990. SchJMediumBullet See separate instructions.
OMB No. 1545-0047
2011
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all the expenses described above? If "No," complete Part III to explain....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
officers, directors, trustees, and the CEO/Executive Director, regarding the items checked in line 1a? ....
2
 
 
3
Indicate which, if any, of the following the organization uses to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ...............
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? ........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? ........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.
5
For persons listed in form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization? .........................
5b
 
No
If "Yes," to line 5a or 5b, describe in Part III.
6
For persons listed in form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ...........................
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," to line 6a or 6b, describe in Part III.
7
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Privacy Act and Paperwork Reduction Act Notice, see the Intructions for Form 990
Cat. No. 50053T
Schedule J (Form 990) 2011

Schedule J (Form 990) 2011
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.

Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and column (E) for that individual.
(A) Name (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation
reported as deferred
in prior Form 990
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
(1) JOHN WALTER (i)
(ii)		 516,875
  		50,000
  		14,868
  		30,870
  		22,298
  		634,911
  		 
 
(2) JAMES T NANGLE (i)
(ii)		 217,599
  		17,194
  		9,891
  		23,479
  		22,069
  		290,232
  		 
 
(3) LOUIS DEGENNARO (i)
(ii)		 331,768
  		32,778
  		17,932
  		24,500
  		15,232
  		422,210
  		 
 
(4) NANCY KLEIN (i)
(ii)		 331,768
  		26,223
  		16,507
  		24,500
  		22,270
  		421,268
  		 
 
(5) RICHARD WINNEKER (i)
(ii)		 221,375
  		25,874
  		22,726
  		5,428
  		982
  		276,385
  		 
 
(6) DAVID TIMKO (i)
(ii)		 230,080
  		5,827
  		11,891
  		23,591
  		15,066
  		286,455
  		 
 
(7) MICHAEL OSSO (i)
(ii)		 207,050
  		20,375
  		17,769
  		21,205
  		15,026
  		281,425
  		 
 
(8) JAY SILVER (i)
(ii)		  
  		 
  		 
  		 
  		 
  		 
  		 
 
(9) DEREK RAGHAVAN (i)
(ii)		  
  		 
  		 
  		 
  		 
  		 
  		 
 







Schedule J (Form 990) 2011

Schedule J (Form 990) 2011
Page 3
Part III
Supplemental Information
Complete this part to provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4c, 5a, 5b, 6a, 6b, 7, and 8. Also complete this part for any additional information.
Identifier Return Reference Explanation
NON-FIXED PAYMENTS PROVIDED SCHEDULE J, PAGE 1, PART I, LINE 7 BONUSES WERE PAID BASED ON THE ACHIEVEMENT OF GROSS REVENUE EXCEEDING BUDGETED GROSS REVENUE,EMPLOYEE INDIVIDUAL PERFORMANCE AND OTHER METRICS. BONUSES WERE CAPPED ACCORDING TO LLS'S POLICY.THESE AMOUNTS ARE REPORTED ON SCHEDULE J PART II,COLUMN(B)(II).
Schedule J (Form 990) 2011

Additional Data


Software ID:  
Software Version:  
SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
NonCash Contributions
Right pointing arrow large imageComplete if the organization answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
OMB No. 1545-0047
2011
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of Contributions or items contributed 		(c)
Noncash contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
noncash contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 71 803,655 MARKET VALUE
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ... X 53    
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( PRINTED ITEMS ) X 2    
26 Other Right pointing arrow large image ( FUNITURE&EQUIP ) X 6    
27 Other Right pointing arrow large image ( VARIOUS ) X 73    
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement ...
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1-28 that it
must hold for at least three years from the date of the initial contribution, and which is not required to be used
for exempt purposes for the entire holding period? ..................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any non-standard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash
contributions? ............................
32a
Yes
 
b
If "Yes," describe in Part II.
33
If the organization did not report revenues in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) 2011
Schedule M (Form 990) 2011
Page 2
Part II
Supplemental Information. Complete this part to provide the information required by Part I, lines 30b,
32b, and 33 and whether the organization is reporting in Part I, column (b) the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.
Identifier Return Reference Explanation
THIRD PARTY USED TO PROCESS NONCASH CONTRIBUTIONS SCHEDULE M, PAGE 1, PART I, LINE 32B LLS USES ITS INVESTMENT CUSTODIAN TO LIQUIDATE ANY DONATED SECURITIES.
EXPLANATION FOR NOT REPORTING REVENUE SCHEDULE M, PAGE 1, PART I, LINE 33 LLS ONLY RECORDS DONATED SECURITIES AS REVENUE. ALL OTHER ITEMS FOR WHICH COLUMN A IS CHECKED ARE NOT RECORDED AS REVENUE OR EXPENSE BECAUSE THEY WOULD NOT HAVE BEEN PURCHASED HAD THEY NOT BEEN DONATED, AND ARE IMMATERIAL IN AMOUNT RELATIVE TO THE STATEMENTS OF LLS.
SUPPLEMENTAL INFORMATION SCHEDULE M, PAGE 2, PART II PART I, COLUMN (B) LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS.
Schedule M (Form 990) 2011
Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
OMB No. 1545-0047
2011
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Identifier Return Reference Explanation
FIRST ACCOMPLISHMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4A TO DATE, LLS HAS INVESTED MORE THAN 875 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2012, LLS SUPPORTED RESEARCH IN THE U.S., CANADA AND 7 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY 66 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: - BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. - TURNING DISCOVERIES INTO NEW THERAPIES: FUNDAMENTAL NEW FINDINGS CAN BE TRANSLATED INTO SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. - SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. - FILLING A VOID: RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY GOVERNMENT AGENCIES OR FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. - SPEEDING NEW TREATMENTS TO PATIENTS: PARTNERING WITH BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES CAN ADVANCE PROMISING THERAPIES THROUGH CLINICAL TESTING, FASTER. PAST ADVANCES MADE WITH LLS RESEARCH FUNDING GENEROUS DONORS HAVE HELPED LLS SUPPORT RESEARCH THAT HAS ALREADY BENEFITED BLOOD CANCER PATIENTS AND MANY OTHERS. ADVANCES INCLUDE: - MULTI-DRUG THERAPIES THAT ARE MORE EFFECTIVE THAN TREATMENTS WITH SINGLE ANTI-CANCER AGENTS, - BONE MARROW / STEM CELL TRANSPLANTATION AND SUPPORTIVE CARE TREATMENTS FOR PATIENTS WHO RELAPSE DESPITE THE BEST AVAILABLE THERAPY, - TESTS THAT DISTINGUISH SPECIFIC CHARACTERISTICS OF PARTICULAR BLOOD CANCERS FOR ACCURATE DIAGNOSIS OF CANCER SUBTYPES, AND FOR "RISK STRATIFICATION" TO SELECT AN OPTIMAL THERAPY. TARGETED THERAPY RESEARCH DISCOVERING THE MOLECULAR ABNORMALITIES THAT CAUSE PARTICULAR TYPES OF BLOOD CANCER HAS BEEN USEFUL IN DIAGNOSIS AND RISK STRATIFICATION, AND IN NEW "TARGETED DRUG" DEVELOPMENT. LLS-FUNDED INVESTIGATORS HAVE HELPED ADVANCE MOLECULARLY TARGETED TREATMENTS THAT CAN SELECTIVELY KILL BLOOD CANCER CELLS VERSUS NORMAL CELLS. MANY OF THESE NEW TREATMENTS BENEFIT NOT ONLY BLOOD CANCER PATIENTS, BUT ALSO PATIENTS WITH OTHER DISEASES. FOR EXAMPLE: - GLEEVEC IS FDA-APPROVED FOR PATIENTS OF ALL AGES WITH CHRONIC MYELOID LEUKEMIA (CML), AND IS ALSO APPROVED FOR PATIENTS WITH ONE FORM OF ACUTE LYMPHOID LEUKEMIA (ALL), MYELODYSPLASTIC SYNDROMES (MDS), MYELOPROLIFERATIVE DISORDERS AND RARE FORMS OF STOMACH AND SKIN CANCERS. RELATED DRUGS, SPRYCEL AND TASIGNA, ARE APPROVED FOR PATIENTS WHO DO NOT BENEFIT FROM GLEEVEC. ONE OR MORE OF THESE DRUGS ARE ALSO SHOWING PROMISE FOR PATIENTS WITH VARIOUS LYMPHOMAS, ACUTE MYELOID LEUKEMIA (AML), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND OTHER CANCERS, INCLUDING BRAIN, BREAST, HEAD-AND-NECK, LUNG, PANCREATIC, AND PROSTATE CANCERS, AND PATIENTS WITH OTHER DISEASES INCLUDING ALZHEIMER'S, ASTHMA AND PULMONARY HYPERTENSION. - RITUXAN WAS THE FIRST FDA-APPROVED, ANTI-CANCER ANTIBODY DRUG, DEVELOPED FOR PATIENTS WITH FORMS OF B-CELL NON-HODGKIN LYMPHOMA (NHL). IT IS NOW ALSO APPROVED FOR CLL PATIENTS AND AS A "MAINTENANCE" THERAPY FOR FOLLICULAR LYMPHOMA PATIENTS, AND SHOWING PROMISE FOR PATIENTS WITH ALL AND AFTER STEM CELL TRANSPLANTATION. IN ADDITION, IT IS APPROVED FOR TREATING PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS AND TWO OTHER TYPES OF AUTOIMMUNE DISEASES. A RELATED ANTIBODY DRUG, ARZERRA, IS APPROVED FOR CLL PATIENTS AND SHOWING WIDER PROMISE. - VELCADE, THALIDOMID AND REVLIMID ARE FDA-APPROVED FOR PATIENTS WITH MYELOMA AND ARE ALSO HELPING SOME PATIENTS WITH HODGKIN LYMPHOMA AND NHL. KRYPOLIS WAS RECENTLY APPROVED FOR MYELOMA PATIENTS FOR WHOM AT LEAST TWO PRIOR THERAPIES WERE INSUFFICIENT. ONE OR MORE OF THESE DRUGS ARE NOW BEING TESTED FOR PATIENTS WITH T-CELL AND B-CELL FORMS OF LYMPHOMA, ACUTE LEUKEMIAS, AS WELL AS AIDS-RELATED KAPOSI SARCOMA AND BRAIN, BREAST, COLORECTAL, HEAD-AND-NECK, KIDNEY, LIVER, LUNG, OVARIAN AND PROSTATE CANCERS, AND ALZHEIMER'S DISEASE. - ISTODAX, ZOLINZA, DACOGEN AND VIDAZA TARGET SMALL CHEMICAL, "EPIGENETIC" CHANGES. THE FIRST TWO DRUGS ARE APPROVED FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMAS; THE LATTER DRUGS ARE APPROVED FOR MDS PATIENTS. ONE OR MORE OF THESE DRUGS ARE BEING TESTED FOR PATIENTS WITH ALL, AML, CML, CLL, MYELOMA AND FORMS OF NHL, AFTER STEM CELL TRANSPLANTATION, AND FOR PATIENTS WITH BREAST, BRAIN, KIDNEY, COLORECTAL, HEAD-AND-NECK, LUNG, STOMACH, PROSTATE AND OVARIAN CANCERS, MELANOMA AS WELL AS SICKLE CELL DISEASE AND PERSISTENT HIV INFECTIONS. OTHER ACTIVE RESEARCH DIRECTIONS LLS-FUNDED RESEARCHERS ARE ALSO EXPLORING OTHER AREAS OF RESEARCH THAT HOLD PROMISE FOR PATIENTS: - NOVEL STEM CELL TRANSPLANTATION PROCEDURES: THESE INCLUDE SO-CALLED "MINI" TRANSPLANTS THAT USE LESS TOXIC PRE-TRANSPLANT TREATMENTS AND ENGINEERED DONOR CELLS THAT HELP REDUCE POST-TRANSPLANT COMPLICATIONS, MAKING THESE POTENTIALLY CURATIVE TREATMENTS AVAILABLE TO MORE PATIENTS. - IMMUNOTHERAPIES: INCLUDING ANTIBODIES, VACCINES AND ENGINEERED IMMUNE CELLS, THESE TARGETED THERAPIES HELP A PATIENT'S IMMUNE SYSTEM FIGHT INFECTIONS AND KILL RESIDUAL CANCER CELLS, PROLONGING REMISSIONS, AND PERHAPS ONE DAY REPLACING TOXIC CHEMOTHERAPIES. - DIAGNOSTICS: NEW TECHNOLOGIES MAKE IT POSSIBLE TO CHARACTERIZE THE ABNORMALITIES IN INDIVIDUAL CANCER CASES IN MOLECULAR DETAIL. THIS INFORMATION CAN BE USED TO HELP CHOOSE THE BEST POSSIBLE TREATMENT FOR EACH PATIENT, ESPECIALLY AS MORE TARGETED THERAPIES BECOME AVAILABLE. - QUALITY OF LIFE RESEARCH: THESE STUDIES INCREASE OUR UNDERSTANDING OF HOW SPECIFIC TREATMENTS CAN CAUSE DEBILITATING SIDE-EFFECTS, INCLUDING LATE-EFFECTS, AND WHICH PATIENTS ARE AT RISK FOR DEVELOPING THESE COMPLICATIONS, SO THAT THEY CAN BE BETTER MANAGED OR EVEN PREVENTED. DRIVING RESEARCH TO ADDRESS UNMET MEDICAL NEEDS LLS CONTINUES TO SOLICIT AND SUPPORT RESEARCH FOCUSED ON IMPROVING BLOOD CANCER PATIENTS' QUALITY OF LIFE AFTER TODAY'S CURATIVE THERAPIES. ALSO IN 2012, FOR THE SECOND YEAR, LLS ACTIVELY RECRUITED RESEARCH PROPOSALS IN THREE OTHER UNDERDEVELOPED RESEARCH AREAS IN WHICH PROGRESS IS LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. NEW RESEARCH IS FOCUSED ON: - THE MALIGNANT STEM CELL IN AML AND MDS - NON-CUTANEOUS T-CELL LEUKEMIAS AND LYMPHOMAS - HIGH RISK MYELOMA CASES THE THERAPY ACCELERATION PROGRAM THIS STRATEGIC INITIATIVE WAS LAUNCHED IN 2007 TO MOVE NEW TREATMENTS AND DIAGNOSTICS THROUGH PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS, FASTER. USING MILESTONE-DRIVEN CONTRACTS AND WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, LLS IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. THE PROGRAM INCLUDES: - THE ACADEMIC CONCIERGE DIVISION IDENTIFIES ESPECIALLY PROMISING LLS-FUNDED GRANT PROJECTS AND PROVIDES ADDITIONAL SUPPORT TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. - THE BIOTECHNOLOGY ACCELERATOR DIVISION PARTNERS LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL BLOOD CANCER THERAPIES THAT OTHERWISE MIGHT NOT BE PRIORITIZED BY THE COMPANY.. - THE CLINICAL TRIALS DIVISION BRINGS CLINICAL TRIALS TO BLOOD CANCER PATIENTS IN THEIR COMMUNITIES, INCLUDING UNDER-REPRESENTED POPULATIONS, AND WITH THE ULTIMATE GOAL OF INCREASING PATIENT ENROLLMENT IN BLOOD CANCER TRIALS.
SECOND ACCOMPLISHMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4B LLS IS COMMITTED TO PROVIDING THE MOST ACCURATE AND UP-TO-DATE BLOOD CANCER INFORMATION. PROFESSIONAL VOLUNTEER CLINICAL ADVISORS WORK WITH LLS STAFF TO REVIEW ALL OF THE INFORMATION LLS PROVIDES THROUGH HEALTHCARE PROFESSIONAL AND PATIENT EDUCATION PROGRAMS, PUBLICATIONS AND THE LLS WEBSITE. A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. LLS PUBLISHES AN ANNUAL COMPILATION OF DATA AVAILABLE FOR BLOOD CANCERS, INCLUDING THE ESTIMATED NUMBERS OF NEW BLOOD CANCER CASES AND DEATHS, THE MOST RECENT STATISTICS AVAILABLE FOR INCIDENCE, MORTALITY AND SURVIVAL; AND CURRENT AND ACCURATE INFORMATION ABOUT SYMPTOMS, RISK FACTORS AND TREATMENT. PUBLICATIONS: AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LLS CHAPTERS. MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH AND SPANISH. - 1,077,533 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2012 FINANCIAL ASSISTANCE IN 2012, A COMBINED 48,018,526 DOLLARS WAS AWARDED TO PATIENTS THROUGH THE LLS PATIENT FINANCIAL AID (3,057,200) AND CO-PAY ASSISTANCE PROGRAMS (45,961,326). PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 46 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM PROVIDES A LIMITED AMOUNT OF FINANCIAL ASSISTANCE TO HELP PATIENTS WITH SIGNIFICANT FINANCIAL NEED AND WHO ARE UNDER A DOCTOR'S CARE FOR A CONFIRMED BLOOD CANCER DIAGNOSIS. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. - 30,603 PATIENTS RECEIVED FINANCIAL AID IN 2012 CO-PAY ASSISTANCE PROGRAM THIS CO-PAY ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 13,971 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2012 COMMUNITY PROGRAMS EACH LLS CHAPTER OFFICE IS STAFFED WITH A PATIENT SERVICES MANAGER (PSM) WHO OVERSEES SERVICES TO PATIENTS AND THEIR FAMILIES, CAREGIVERS AND HEALTHCARE PROFESSIONALS. PSMS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. PSMS SERVE AS LIAISONS WITH COMMUNITY AND REGIONAL ONCOLOGY/HEMATOLOGY HEALTHCARE PROFESSIONALS AND TREATMENT CENTERS.COMMUNITY-BASED EDUCATION AND OUTREACH, SUPPORT AND PUBLIC POLICY AND ADVOCACY PROGRAMS ARE AVAILABLE. - 43,282 PATIENT AND CAREGIVER PARTICIPANTS IN 2012 - 11,424 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2012 PROGRAMS FOR CHILDREN AND YOUNG ADULTS THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER FOCUSES ON INCREASING COMMUNICATION AMONG HEALTHCARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO SUPPORT CHILDREN, ADOLESCENTS AND YOUNG ADULTS LIVING WITH CANCER. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE IN COMMUNITIES THROUGHOUT THE US AND CANADA VIA LLS CHAPTER OFFICES. THE PROGRAM INCLUDES STAYING CONNECTED: FACILITATING THE LEARNING EXPERIENCE DURING AND AFTER CANCER TREATMENT. THIS EDUCATION PROGRAM FOR SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS DESCRIBES PHYSICAL, COGNITIVE AND PSYCHOSOCIAL SHORT-AND LONG-TERM EFFECTS THAT CHILDREN, ADOLESCENTS AND YOUNG ADULTS MAY EXPERIENCE DURING AND AFTER TREATMENT. THE PROGRAM OFFERS GUIDANCE AND NUMEROUS RESOURCES TO HELP CHILDREN, ADOLESCENTS AND YOUNG ADULTS CONTINUE THEIR EDUCATION DURING AND AFTER TREATMENT. - 2,957 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 81 STAYING CONNECTED PROGRAMS ACROSS THE US AND CANADA IN 2012. FAMILY SUPPORT GROUPS LLS HAS DEVELOPED 419 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS 786 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, PROVIDING INFORMATION AND SUPPORT AND ENCOURAGING GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTHCARE PROFESSIONALS. - 12,113 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2012 PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 6,050 FIRST CONNECTIONS IN 2012
THIRD ACCOMPLISHMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4C LLS INFORMATION SPECIALISTS ARE MASTER'S LEVEL ONCOLOGY SOCIAL WORKERS, NURSES AND HEALTH EDUCATORS WHO PROVIDE HELP WITH DISEASE, TREATMENT AND CLINICAL TRIAL INFORMATION AND SUPPORT. LLS INFORMATION SPECIALISTS CONDUCT CLINICAL-TRIAL SEARCHES TO HELP PATIENTS WORK WITH THEIR DOCTORS TO FIND OUT ABOUT SPECIFIC CLINICAL TRIALS. PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET, EMAIL INFOCENTER@LLS.ORG OR CHAT ONE-ON-ONE VIA THE LLS WEBSITE. THE INFORMATION RESOURCE CENTER OFFERS TRANSLATION SERVICES IN MORE THAN 165 LANGUAGES. - 60,012 INQUIRIES IN 2012 THE LLS WEBSITE THE LLS WEBSITE, WWW.LLS.ORG, FULFILLS A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. VISITORS CAN PERSONALIZE THEIR WEB PAGES TO KEEP CURRENT WITH DISEASE-SPECIFIC UPDATES AND COMMUNITY EDUCATION AND SUPPORT ACTIVITIES. THE WEBSITE PROVIDES ACCESS TO LLS PROGRAMS AND SERVICES, INCLUDING CO-PAY ASSISTANCE, PATIENT FINANCIAL AID, THE MOST CURRENT AND ACCURATE INFORMATION AND STATISTICS, WEEKLY FACILITATED ONLINE CHATS, NATIONAL TELEPHONE AND WEB EDUCATION PROGRAMS, PUBLICATIONS IN ENGLISH AND SPANISH, AND CLINICAL-TRIAL SEARCHES VIA AN ONLINE CLINICAL-TRIAL SEARCH SERVICE THAT OFFERS PATIENTS AND CAREGIVERS IMMEDIATE ACCESS TO LISTINGS OF BLOOD CANCER CLINICAL TRIALS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS AND ONE ANOTHER THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. NATIONAL TELEPHONE/ WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. IN 2012, 10 LLS NATIONAL EDUCATION PROGRAMS FEATURED DISEASE-SPECIFIC UPDATES AND INFORMATION ABOUT TREATMENT OPTIONS FROM WORLD RENOWNED CLINICAL EXPERTS. OPPORTUNITIES ARE PROVIDED TO ASK QUESTIONS OF EXPERTS DURING THESE PROGRAMS. MANY OF THESE PROGRAMS INCLUDE CONTINUING EDUCATION CREDITS FOR NURSES AND SOCIAL WORKERS. LLS ALSO SPONSORS A RANGE OF PROFESSIONAL EDUCATION PROGRAMS. RECENT PROGRAMS EXPLORED COMMUNICATION AMONG PRIMARY CARE PROVIDERS AND HEMATOLOGISTS/ONCOLOGISTS IN MANAGING PATIENTS WITH HEMATOLOGIC CANCER AND NURSING MANAGEMENT OF CHALLENGING SIDE EFFECTS. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. PROFESSIONAL EDUCATION PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PROFESSIONALED. LLS ALSO OFFERS DISEASE-SPECIFIC WEBCASTS PRESENTED BY WORLD RENOWNED CLINICAL EXPERTS. THESE CAN BE ACCESSED AT WWW.LLS.ORG/WEBCASTS.
ALL OTHER ACCOMPLISHMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4D D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT.
FINANCIAL ACCOUNTS IN FOREIGN COUNTRIES FORM 990, PART V, LINE 4B CANADA
CLASSES OF MEMBERS OR STOCKHOLDERS FORM 990, PAGE 6, PART VI, LINE 6 THE MEMBERS OF LLS CONSIST OF ONE ELECTED REPRESENTATIVE FROM EACH CHAPTER.
ELECTION OF MEMBERS AND THEIR RIGHTS FORM 990, PAGE 6, PART VI, LINE 7A THE BOARD OF REPRESENTATIVES (REPRESENTING THE CHAPTERS) ELECTS THE MEMBERS OF LLS'S GOVERNING BODY, ITS NATIONAL BOARD OF DIRECTORS.
DECISIONS SUBJECT TO APPROVAL OF MEMBERS FORM 990, PAGE 6, PART VI, LINE 7B SIGNIFICANT DECISIONS AFFECTING THE CHAPTERS REQUIRE AN APPROVING VOTE BY THE CHAPTER DELEGATES. DECISIONS NOT SIGNIFICANTLY AFFECTING THE CHAPTERS DO NOT REQUIRE APPROVAL FROM THE CHAPTER DELEGATES.
ORGANIZATION'S PROCESS USED TO REVIEW FORM 990 FORM 990, PAGE 6, PART VI, LINE 11B THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, VICE PRESIDENT OF FINANCE, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990 WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING BY POSTING THE FORM ON AN INTRANET WEBSITE.
ENFORCEMENT OF CONFLICTS POLICY FORM 990, PAGE 6, PART VI, LINE 12C ALL EMPLOYEES, BOARD OF DIRECTORS MEMBERS, BOARD OF REPRESENTATIVES MEMBERS, CHAPTER BOARD MEMBERS, FAMILY SUPPORT GROUP FACILITATORS, AND TNT COACHES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL FORMS ARE COLLECTED AND THE AUDIT COMMITTEE REVIEWS ANY FORMS DISCLOSING A POSSIBLE CONFLICT OF INTEREST AND DETERMINES WHETHER OR NOT A CONFLICT EXISTS.
COMPENSATION PROCESS FOR TOP OFFICIAL FORM 990, PAGE 6, PART VI, LINE 15A THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWS AND MONITORS THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. THE COMMITTEE OBTAINED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES.
COMPENSATION PROCESS FOR OFFICERS FORM 990, PAGE 6, PART VI, LINE 15B THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND COMPARED THIS TO THE OTHER OFFICER'S SALARY AND DETERMINED THAT IT WAS APPROPRIATE. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES.
STATES WHERE COPY OF RETURN IS FILED FORM 990, PAGE 6, PART VI, LINE 17 , ALASKA, ALABAMA, ARKANSAS, ARIZONA, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DIST OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, IDAHO, ILLINOIS, INDIANA, KANSAS, KENTUCKY, LOUISIANA, MASSACHUSETTS, MARYLAND, MAINE, MICHIGAN, MINNESOTA, MISSOURI, MISSISSIPPI, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEBRASKA, NEW YORK, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PUERTO RICO, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, UTAH, VIRGINIA, WASHINGTON, WISCONSIN, WEST VIRGINIA
GOVERNING DOCUMENTS DISCLOSURE EXPLANATION FORM 990, PAGE 6, PART VI, LINE 19 THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE, WHEN CHANGES ARE MADE, AS PART OF THE 990 AVAILABLE FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990.
RELATED ORGANIZATIONS FORM 990, PAGE 7, PART VII JOHN WALTER PRESIDENT & CEO, SCOTT CARROLL BOD CHAIR, TIMOTHY DURST BOD VICECHAIR, AND STEVEN HOOKER BOD SECRETARY/TREASURER SPEND LESS THAN 1 HOUR PER MONTH ON THE BUSINESS OF OUR RELATED ORGANIZATIONS LSRP13-3470494,AND LSRF 13-3709252. THE LARGEST AMOUNT OF TIME THEY SPEND ON LSRF AND LSRP IS DURING THEIR ANNUAL REVIEW OF THE ORGANIZATIONS IRS FORM 990, AND 990EZ FILINGS.
OTHER CHANGES IN NET ASSETS EXPLANATION FORM 990, PART XI, LINE 5 RECONCILIATION OF CHANGE IN NET ASSETS ON A CONSOLIDATED BASIS TO SEPARATE COMPANY BASIS: CHANGE IN NET ASSETS PER AUDITED FINANCIAL STATEMENTS (6,266,084) PLUS: CHANGE IN NET ASSETS LLS CANADA 439,080 PLUS: LLSRF AND LLSRP ACTIVITY (41,507) PLUS: FOREIGN CURRENCY TRANSLATION ADJUSTMENT 133,400 PLUS: AUDITED FINANCIAL STATEMENT ROUNDING (3) EQUALS: CHANGE IN NET ASSETS PER 990 (5,735,114) SCHEDULE D PART XI LINE 9 (6,694,563) CHANGE IN NET ASSETS ABOVE 530,970 990 PART XI LINE 5 (6,163,593) THE AUDITED FINANCIAL STATEMENTS FOR THE LEUKEMIA & LYMPHOMA SOCIETY, INC. INCLUDE THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA, THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH PROGRAMS, INC., AND THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH FOUNDATION IN ADDITION TO LLS.
ADDITIONAL INFORMATION FORM 990, PART XII JAY SILVER RESIGNED FROM THE BOD APRIL 20, 2012 DEREK RAGHAVAN RESIGNED FROM THE BOD MARCH 14, 2012
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2011

Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" to Form 990, Part IV, line 33, 34, 35, 36, or 37.
MediumBulletAttach to Form 990. MediumBullet See separate instructions.

OMB No. 1545-0047
2011
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA SOCIETYINC
 
Employer identification number

13-5644916
Part I
Identification of Disregarded Entities (Complete if the organization answered "Yes" on Form 990, Part IV, line 33.)
(a)
Name, address, and EIN of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income
(e)
End-of-year assets


 		(f)
Direct controlling
entity

















Part II
Identification of Related Tax-Exempt Organizations (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.)
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section
(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled organization
Yes No
(1) THE LLS OF CANADA

804 2 LANSING SQUARE
TORONTO   M2J4P8
CA
PART VII CA     NA
 
 
No
(2) THE LLS RESEARCH PROGRAMS INC

1311 MAMARONECK AVENUE

WHITE PLAINS,NY10605
13-3470494 		PART VII DE 501C3 11B LLS INC
 
Yes
 
(3) THE LLS RESEARCH FOUNDATION

1311 MAMARONECK AVENUE

WHITE PLAINS,NY10605
13-3709252 		PART VII DE 501C3 11B LLS INC
 
Yes
 








For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2011
Schedule R (Form 990) 2011
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.)
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V—UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.)
(a)
Name, address, and EIN of related organization



 		(b)
Primary activity



 		(c)
Legal domicile
(state or
foreign
country)
 		(d)
Direct controlling
entity


 		(e)
Type of entity
(C corp, S corp,
or trust)

 		(f)
Share of total income



 		(g)
Share of
end-of-year
assets

 		(h)
Percentage
ownership












Schedule R (Form 990) 2011
Schedule R (Form 990) 2011
Page 3
Part V
Transactions With Related Organizations (Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35, 35A, or 36.)
Note. Complete line 1 if any entity is listed in Parts II, III or IV.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest (ii) annuities (iii) royalties (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .
1a
 
No
b Gift, grant, or capital contribution to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1b
 
No
c Gift, grant, or capital contribution from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1d
Yes
 
e Loans or loan guarantees by related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1e
 
No
f Sale of assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1f
 
No
g Purchase of assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1g
 
No
h Exchange of assets with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1h
 
No
i Lease of facilities, equipment, or other assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1i
 
No
j Lease of facilities, equipment, or other assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .
1j
 
No
k Performance of services or membership or fundraising solicitations for related organization(s) . . . . . . . . . . . . . . . . . . . .
1k
 
No
l Performance of services or membership or fundraising solicitations by related organization(s) . . . . . . . . . . . . . . . . . . . .
1l
 
No
m Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) . . . . . . . . . . . . . . . . . . . . .
1m
Yes
 
n Sharing of paid employees with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1n
Yes
 
o Reimbursement paid to related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1o
 
No
p Reimbursement paid by related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1p
 
No
q Other transfer of cash or property to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1q
 
No
r Other transfer of cash or property from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1r
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of other organization 		(b)
Transaction
type(a-r) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) THE LEUKEMIA & LYMPHOMA SOCIETY

 D 164,921 COST
(2) OF CANADA

      
(3)
(4)
(5)
(6)
Schedule R (Form 990) 2011
Schedule R (Form 990) 2011
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership (Complete if the organization answered "Yes" on Form 990, Part IV, line 37.)
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(e)
Are all
partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V—UBI
amount in box
20 of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2011
Schedule R (Form 990) 2011
Page 5
Part VII
Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule R (see instructions).
Identifier Return Reference Explanation
GROUP EXEMPTION RELATIONSHIPS SCHEDULE R THE LEUKEMIA LYMPHOMA SOCIETY OF CANADA CARRIES OUT THE SAME PRIMARY ACTIVITIES AS THE LEUKEMIA LYMPHOMA SOCIETY INC IN CANADA THE LEUKEMIA SOCIETY RESEARCH PROGRAMS INC AND THE LEUKEMIA RESEARCH FOUNDATION INC SUPPORT THE ACTIVITIES OF THE LEUKEMIA LYMPHOMA SOCIETY INC
Additional Data


Software ID:  
Software Version: